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CHAPTER I

INTRODUCTION

Bone resorption is the process by which the organic and inorganic components of the skeleton are degraded and removed.

Bone resorp-

tion, closely linked with bone formation, allows for growth, maintenance and repair of the skeleton.

The principal effector cell of the

osteolytic process is the osteoclast, however bone forming cells, monocytes, macrophages and their derivatives are capable of bone removal.
The direct and/or indirect roles of these accessory cells in the
physiological and pathological processes of osteolysis may be significant.

Because of its destructive potential to the organism, bone

resorption is highly regulated.

If this process dysfunctions due to a

cellular or regulatory defect, bone loss may result either thoughout
the skeleton as in osteoporosis or in a localized area as in rheumatoid
arthritis.
threatening.

In either case the effects can be debilitating or life
Although the effects of physiological and pathological

bone loss are apparent, knowledge of the process, especially in the
disease state, is limited and further investigation is necessary.
Implantation of mineralized bone matrix into subcutaneous sites
results in a rapid, cell-mediated osteolytic response (Glowacki et al.,
1981; Glowacki and Cox, 1986).

Histological evaluation of the implant

site revealed mononuclear and multinucleated giant cells (MNGC)s
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2
contacting the bone particles.

Although it has been suggested that the

MNGCs surrounding the bone surface are indeed osteoclasts, indicating
this system can be used to study physiological bone resorption; it has
been shown that MNGGs derived from the mononuclear phagocyte system
also have osteolytic capabilities and may be present at the site
(Walters and Schneider, 1985).

Multinucleated giant cells are formed

by fusion of mature mononuclear phagocytes in response to a foreign
body infitrate or chronic inflammation (Adams, 1976).

Sufficient

evidence has not been presented to substantiate the use of this model
system for physiological bone resorption.

This model may be bet- ter

suited for the study of pathological bone loss which is mediated by
mononuclear and multinuclear phagocytic cells.

In either case, this

model system may be a valuable tool to study the osteolytic process.
The osteoclast is both unique morphologically and functionally.
However, other than the morphological features of multiple nuclei and
ruffled borders, which are highly reliable but not always apparent in a
histological section, there are few means of easily and quickly distinguishing osteoclasts from other bone cells and macrophages.

Recently,

the presence of tartrate resistant acid phosphatase (TRAP) in osteoclasts and their precursors has been used for identification in both
normal and experimental situations.

TRAP can be easily demonstrated,

however the specificity of the enzyme to osteoclasts and the reliability of using it in experimental situations have been questioned
(Hattersley and Chambers, 1989).

In the first study of this disserta-

tion, a method using image analysis was devised for quantitating TRAP

3

activity and defining a level which was specific for the osteoclast.
To define the level of TRAP expression, osteoclasts from rat proximal
tibiae and cells generated at the subcutaneous site of implanted mineralized bone matrix were reacted for TRAP and compared.

This level of

TRAP expression could be used to characterize osteoclasts in both normal and experimental situations.

Previously, only the presence of the

enzyme or a subjective evaluation of TRAP expression had been used.
In the next study the subcutaneous bone implant was assessed as
a model system for bone resorption.

The influence of three prepara-

tions of bone matrix- mineralized, demineralized and a mineralized/
demineralized composite- on the recruitment of multinucleated giant
cells to the implant site was investigated.

The cells surrounding each

of the three types of bone matrix were characterized using level of
TRAP expression and ultrastructure as criteria.

TRAP expression and

ultrastructure of the MNGCs were compared to TRAP expression and ultrastructure of normal osteoclasts.

The final studies employed the use of

hormones and a cytokine to modulate the cellular response to the three
types of bone implants. The histochemical and morphological effects of
these substances to modulate or to transform the MNGCs into osteoclasts
at the site were determined.
In summary, the primary goal of this investigation is a better
understanding of the process of bone resorption through characterization of the cells elicited by the implanted bone matrix.

The osteoly-

tic potential of cells, other than osteoclasts, that are commonly present and may be active in osteolytic disease states must be assessed to
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determine their role in the process of pathological bone resorption.
Clinically, bone implants and transplants are used extensively in
corrective neurological and orthopedic surgeries and craniofacial
reconstructive surgeries, mainly to promote localized bone formation.
The extent of mineralization of a devitalized bone implant has a direct
effect on its ability to form bone.

The implant system described here

may be used to evaluate the effectiveness and subsequent cell-mediated
resorption of some clinical bone implants.

It may also be used to as-

sess the direct role of monocytes and/or macrophages in pathological
bone destruction.

Characterization of the cells elicted to implanted

bone matrix will determine whether the in vivo model system reflects
osteoclastic resorption or monocyte-macrophage bone destruction, which
has been implicated in osteolytic disease states.

Bone resorption is a

cell-mediated process, coupled with bone formation, which is able to
precisely mold and define the form of the growing and fully developed
skeleton.
dated.

Most of the details of this process are yet to be eluci-

CHAPTER II

REVIEW OF REIATED LITERATURE

Osteoclast Morphology and Function
Ostoklast was the name given to the multinucleated cell found in
the bone microenvironment.

Based on circumstantial evidence, as early

as 1852, Tomes and de Morgan proposed that bone resorption was a cellmediated process, however, they were unable to fully characterize the
cells, the factors responsible for their occurrence, their distribution
or regulation.

Subsequent observations described the multinucleated

cell in areas of bone loss but did not propose a function for it.
Although the multinucleated cell of bone had been described over twenty
years previously, the suggestion that bone removal was the principal
function of the osteoclast was not proposed until 1872, by Kolliker
when he named the cell.

Since the osteoclast's identification, the

mechanism of its function, its regulation and origin have been the subjects of numerous investigations and controversies.
The osteoclast can be distinguished from other types of multinucleated giant cells by its location next to the bone surface and a
combination of characteristic membrane specializations indicative of
its function, bone removal.

At the light microscopic level, the osteo-

clast is characteristically a large cell with multiple nuclei.

Present

in the area of bone removal, the osteoclast is found along the bone
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sur f ac e

in cavities or pits called Howship's lacunae.

The cytoplasm is

. ble and can range from basophilic to acidophilic (Gothlin and
var1a
Ericsson, 1976).

The definitive feature of an active osteoclast how-

eve r , is the brush or striated border which is made up of fine cytoplasmic processes located along the bone-cell interface.
Ultrastructurally, the morphological features of the osteoclast
have been described in detail.

As was seen at the light microscopic

level, the most conspicuous features are the large size and multiple
nuclei arranged in a cluster.

However, the feature that morpholog-

ically defines the osteoclast is the ruffled border.

The ruffled

border, which is equivalent to the brush border at the light microscopic level, is a specialized area of the cell membrane in contact
with the bone surface.

The ruffled appearance is due to an irregular

complex system of cytoplasmic infoldings which exhibit a coated membrane structure (Kallio et al., 1971).

Subjacent to the ruffled border

are vacuoles and vesicles, which have been shown to contain bone salt
crystals.

The ruffled border area has been implicated as the area of

bone resorption based on the coated cell membrane, which may facilitate
formation of the cytoplasmic vesicles, and the presence of bone salt
crystals within vacuoles in the area subjacent to the ruffled border.
Baron et al. (1985) have shown that the extracellular space bound by
the ruffled border and the bone surface is actively acidified by the
secretion of lysosomal enzymes by the osteoclast.

Also, the extracel-

lular surface of the ruffled border membrane expresses a 100-kD protein
similar or identical to those expressed in the limiting membrane of
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secondary lysosomes and other acidified organelles.

Antibodies to the

100-kD protein cross-react with a proton-pump ATPase from pig gastric
mucosa and may perform a similar function of acidification via proton
transfer across the membrane.

Another feature of the osteoclast, which

is not exclusive but necessary for bone resorption, is the clear zone.
The clear zone, as the name implies, is an organelle free zone, which
contains actin and surrounds the ruffled border in an active cell.

It

may also be present in inactive osteoclasts and active macrophages and
monocytes cultured with devitalized bone particles (King and Holtrop,
1975; Teitelbaum and Kahn, 1980).

The clear zone aids in the resorp-

tion process by anchoring the cell firmly to the bone substrate and
isolating the active resorption site, the ruffled border area.

The

cell characteristically exhibits a high concentration of lysosomes and
ribosomes.

Mitochondria are also seen in large numbers, scattered

throughout the cytoplasm except in the area of the ruffled border.

An

extensive Golgi apparatus is present around the clustered nuclei.
Also, found in a clustered arrangement, are numerous centrioles, which
form a centrosphere (Matthews et al., 1967).

Prior to its identifica-

tion in foreign body giant cells, the centrosphere was believed to be
an exclusive feature of the osteoclast (Sapp, 1976).

The centrosphere

has provided a plausible explanation for the lack of mitotic figures
and formation of the osteoclast by cell fusion.

Because of their

clustered arrangement at a distance from the nuclei, the centrioles
would probably not be avaliable for nuclear/cell division.
Histochemically, the osteoclast can be characterized by.the
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presence of a specific hydrolytic enzyme, the tartrate resistant form
of acid phosphatase (TRAP).

Acid phosphatases are lysosomal enzymes

that have been classically divided into two groups, based on their
sensitivity to tartrate.

The tartrate sensitive isoenzyme has been

identified in all animal cells except the erythrocyte (Anderson and
Toverund, 1986).

The tartrate resistant form has been identified in

human leukocytes and more recently in bone (Li et al., 1970; Minkin,
1982).

TRAP has been proposed to be a marker for osteoclast differen-

tiation and function (van de Wijngaert and Burger, 1986; Minkin, 1982).
Scheven et al. (1985) have shown the immediate osteoclast precursor is
a mononuclear, nonproliferative cell exhibiting TRAP activity.

Minkin

(1982) observed significant increases in TRAP activity in the media of
newborn mouse calvaria cultures which had been stimulated to induce
bone resorption, relative to control cultures.
Another biochemical marker proposed for characterization of the
osteoclast is carbonic anhydrase.

The function of this enzyme is to

catalyze the reversible hydration of

co 2 .

fer or produce H+ or HC0 + rich solutions.
3

It can facilitate gas transGay and Mueller (1974)

isolated carbonic anhydrase in chicken osteoclasts and suggested that
its role in H+ secretion which could be directly linked to mineral
resorption.

Vaananen and Parvinen (1983) were able to identify the

c-isoenzyme of carbonic anhydrase in rat calvarial osteoclasts.
Carbonic anhydrase inhibition studies which showed successful inhibition of bone resorption suggest a role for the enzyme in osteoclastmediated bone resorption.

Administration of osteotropic hormones,

9

parathyroid hormone, calcitonin and 1,25 dihydroxyvitamin

o3 ,

have been

shown to influence either the location or the activity of carbonic
anhydrase in osteoclasts in vitro (Cao and Gay, 1985; Hall and Kenny,
1985).
The function of the osteoclast as the effector of bone resorption was proposed over 100 years ago and was initially supported by
histological evidence.

The classic theory of the bone resorption

process indicates that the osteoclast dissolves the bone mineral
extracellularly by secretion of acid and chelating agents and then
phagocytoses the resorption products, both inorganic mineral and organic matrix components (Sakamoto and Sakamoto, 1986).

Although this

theory has been accepted, there are areas of uncertainty and controversy; specifically, the collagenolytic potential of osteoclasts and
the sequence of events in the process.

Bone mineral has been identi-

fied within the vacuoles of osteoclasts substantiating osteoclastic
uptake of the inorganic components.

However, bone collagen has not

been seen within the osteoclast and investigators have used this to
support the possible role of an auxillary cell responsible for the
removal of the organic matrix components.

Heersche (1978) proposed a

combined effort by the osteoclast, responsible for the mineral dissolution, and a fibroblast or macrophage, responsible for organic matrix
removal.

Sakamoto and Sakamoto (1982) suggested that bone resorption

occurs in two phases.

The first phase involves enzymatic removal of

matrix collagen by osteoblastic collagenase followed by a second phase
of osteoclastic digestion of the bone crystal.

However, Chambers et
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al. (1984), using in vitro techniques, have shown the ability of the
osteoclast to digest both components of the bone matrix.

Hormonal Control of Bone Cell Function
Osteoclastic formation and function is regulated directly and
indirectly by a host of calcemic hormones, cytokines and growth factors.

Calcemic hormones not only regulate the function of the cells

responsible for bone remodelling but also play a role in calcium homeostasis.

Parathyroid hormone (PTH) and 1,25 dihydroxyvitamin

n3

(1,25

(OH) D ) have stimulatory effects on bone resorption, however receptors
2 3
for these hormones have not been demonstrated on the osteoclast (Rouleau et al., 1986; Silve et al., 1982).

The effects of PTH and 1,25

(OH) D ) must therefore, be mediated by an indirect mechanism.
2 3

When

osteoclasts are mechanically removed from neonatal rat long bones and
allowed to adhere to slices of cortical bone, excavation of the bone
surface by the isolated osteoclasts begins within hours and can be
quantified by scanning electron microscopic analysis of the bone
surface.

This technique forms the basis for a bioassay by which the

effects of hormones on bone resorption can be assessed (Chambers et
al., 1985).

PTH and l,25(0H) D administration did not influence the
2 3

resorption potential of the isolated osteoclasts (Chambers et al.,
1985).

However, if the osteoclasts are cultured with either osteo-

blastic cell lines, primary cultures of osteoblasts or the supernatant
from PTH or l,25(0H) n stimulated osteoblastic cells, the increase in
2 3
resorption is 2 to 4 times that seen without hormone (McSheehy and
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Chambers, 1986a; McSheehy and Chambers, 1986b).

In vitro investiga-

tions using isolated osteoblasts and osteoclasts indicated that the
activation of osteoclasts by PTH was dependent on the presence of
osteoblasts.

Rodan and Martin (1981) suggested a role for the osteo-

blast in physiological bone resorption based on identification of
receptors and its responsiveness to the bone resorbing hormones.
Qsteoblasts, which form a cellular barrier over the bone surface, have
been shown to change their shape and uncover the bone surface in response to PTH and prostanoids.

The uncovered bone surface is then

exposed to the osteoclasts for degradation.

Also, osteoblasts secrete

collagenase and increase the rate of collagenase secretion when stimulated by PTH (Puzas and Brand, 1979; Sakamoto and Sakamoto, 1982).
They are able to remove the unmineralized organic layer to expose the
subjacent mineral (Chambers and Fuller, 1985).

This is an important

finding since it has been shown in vitro, that osteoclasts excavate the
bone surface only if placed on a mineralized surface and were not able
to excavate pits if placed on an unmineralized surface.
PTH facilitates bone resorption in vivo by increasing (1) the
number of osteoclasts; (2) the number of nuclei per cell, denoting an
increase in formation by increased fusion; (3) the proportion of osteoclasts exhibiting ruffled borders; and (4) the extent of the ruffled
border.

In vivo, increases in osteoclast number in the rat rib have

been detected as early as 30 minutes after the administration of PTH
(Burger et al., 1986).

An increased number of nuclei per cell has been

documented to occur as early as 1 hour after PTH administration in kit-
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tens (Addison, 1979).

Holtrop et al. (1979) demonstrated an increase

in the average size of the ruffled borders, the clear zones and the
cells after injection of SO U of purified bovine PTH.

The effects of

PTH on osteoclast function include increased synthesis and secretion of
acid phosphatase and

~glucuronidase

and increased acidity in the

extracellular space bound by the ruffled border and bone. (Vaes 1965,
1968; Anderson et al., 1985, 1986).
It remains questionable whether PTH has an effect at the level
of osteoclast differentiation.

Fuller and Chambers (1987) incubated

rabbit bone marrow cells or cells from neonatal rabbit spleen for up to
4 weeks on plastic cover glasses and bone slices in the presence of
PTH, l,2S(OH) n and interleukin-1 (IL-1) or a combination of these
2 3
hormones and the cytokine.

Using an osteoclast specific antibody

(Horton et al., 1985) and the ability to excavate bone slices as
criteria for osteoclast identification, osteoclasts were seen only in
cultures of bone marrow or spleen incubated with l,2S(OH) n , indica2 3
ting PTH had no effect on differentiation in this culture system.
Perris (1971) however, reported PTH administration in vivo stimulated
mitosis in rat bone marrow, thymus and liver. This response to PTH was
shown to be mediated by an increase in plasma calcium.

In

short

term incubations with PTH stimulated rnitogenesis in hernopoietic stern
cells (Gallien-Lartigne and Carrez, 1974).

Since osteoclasts are of

hernopoietic origin (Marks, 1983; Chambers, 1985), the increase in
osteoclast number seen with PTH administration may be a result of rnitogenic stimulation of the bone marrow.
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PTH has also been shown to reduce bone formation by directly
affecting osteoblast activity.

In vitro investigations revealed that

the administration of the hormone reduced osteogenesis by inhibiting
the synthesis and secretion of matrix proteins including collagen and
osteocalcin, profoundly decreased citrate decarboxylation, and possibly
inhibited alkaline phosphatase (Kream et al., 1980; Dietrich et al.,
1976; Lian and Canalis, 1985; Beresford et al., 1984; Luben and Cohn,
1976; Luben et al., 1976).

In vivo, PTH has been shown to cause both

inhibition as an acute effect (Bingham et al., 1969) and stimulation as
a long term effect (Tam et al., 1982).

Intermittent exposure to low

levels of hormone similar to the physiological release, produces increased number and activity of osteoblasts.

Recently, Slovik (1986)

reported increased bone mass in osteoporotic patients with a treatment
regimen of intermittent low doses of PTH and l,25(0H) D .
2 3

Sustained

exposure of PTH, both in vitro and in vivo, causes a catabolic response
including reduced collagen synthesis and increased resorption by secretion of plasminogen activator and collagenase (Hamilton et al., 1985).
The effects of 1,25 dihydroxyvitamin

o3

have not been fully

characterized, however evidence has been presented in support of its
role in both bone formation and resorption.

Receptors for l,25(0H)

o

2 3

have been detected only in osteoblasts and preosteoblasts (Kream et
al., 1977; Manologas et al., 1979).

Using isolated osteoclasts,

Chambers and colleagues (Chambers and Fuller, 1985; Chambers et al.,
1985) have shown no effect of l,25(0H)
bone resorption.

o

2 3

on cytoplasmic motility or

However, l,25(0H) D has been shown to stimulate bone
2 3
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resorption in vivo and in bone organ cultures.

Administration of 1,25

n to l,25(0H) 2n3 deficient rats increased the number of osteo2 3
clasts (Yoshiki et al., 1974). As was the case with PTH, the effects
(OH)

of l,25(0H) D on osteoclast function may be mediated by another cell
2 3
in the bone microenvironment, possibly the osteoblast.
A number of studies on several tumor cell lines have shown that
l,25(0H) n induces differentiation along the monocyte/macrophage path·
2 3
way (Abe et al., 1981; Tanaka et al., 1983; Bar-Shavit et al., 1983;
McCarthy et al., 1983).

Differentiation promoting properties include

enhanced adhesion to substrates, increased phagocytic activity including degradation of bone particles, expression of moncyte/macrophage
morphology, enzymes and cell surface antigenic determinants.

Adminis·

tration of l,25(0H) D to mouse alveolar macrophage cultures promoted
2 3
the formation of macrophage derived multinucleated giant cells (Abe et
al., 1981).

If these data can be extrapolated, based on similarities

between progenitors of monocyte/macrophage and osteoclasts, the results
suggest that l,25(0H)

n

2 3

may promote the differentiation and fusion of

osteoclast precursors.
Long term bone marrow cultures with and without l,25(0H) D
2 3
administration have been shown to promote MNGC formation (Allen et al.,
1981; Testa et al., 1981; Ibbotson et al., 1984; Roodman et al., 1985;
MacDonald et al., 1986, 1987).

Originally the MNGCs formed in these

cultures were believed to be osteoclasts however, the results from this
system were easily misinterpreted since macrophage-derived MNGCs, which
resemble osteoclasts, were also formed.

Standard criteria for identi·
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fication is essential, however osteoclasts generated in vitro may not
necessarily express the same characteristics as those in vivo.
and Chambers (1987) reported l,25(0H)

n

2 3

Fuller

was essential for osteoclast

differentiation but not for macrophage-derived MNGC formation in this
system.

Criteria for identification of osteoclasts in this investi-

gation included staining with an osteoclast specific monoclonal antibody and the most discriminatory characteristic, excavation of bone
slices.

The cells that met both criteria were often mononuclear or had

few nuclei and were not the MNGCs that had been described in previous
long term bone marrow investigations (Testa et al., 1981; Pharaoh and
Heersche, 1985; Roodman et al., 1985).
Bone formation and mineralization is also affected by the
administration of l,25(0H) D .
2 3

Continuous infusion of the hormone in

normal, young mice promoted calcification of bone matrix (Reynolds et
al., 1976; Marie et al., 1985).

However, the opposite results have

been reported in rats (Wronski et al., 1986).

Rickets, a childhood

disease of reduced mineralization due to reduced l,25(0H)

o

2 3

, is

characterized by low levels of serum calcium and phosphate which are
insuffient to promote mineralization.

l,25(0H) D supplements which
2 3

elevate serum calcium and phosphate to normal levels have been shown to
correct the disease.
are conflicting.

The effects of l,25(0H) n on osteoblast activity
2 3

In vivo infusion studies and organ cultures of fetal

bone indicated decreased matrix apposition rates and inhibition of
collagen synthesis respectively (Marie et al., 1985; Raisz et al.,
1978).

Investigations using cultures of osteoblast or osteoblast-like
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cells have indicated both stimulation and inhibition of activity
(Haneji et al., 1983; Manolagas et al., 1981; Chen et al., 1983; Wong
et al., 1977).

Along with its effects on bone cells, l,25(0H) D may
2 3

also play an immunoregulatory role which could indirectly influence
bone resorption by regulating the synthesis and release of immune cell
products known to affect bone remodelling (Bhalla et al., 1986; Holder
et al., 1985).

The complex effects of l,25(0H) D suggest its possible
2 3

role in the linking mechanism between bone formation and resorption.
Unlike PTH and l,25(0H) D which have stimulatory effects and
2 3
act in an indirect fashion on osteoclast activity and formation,
calcitonin (CT) has been shown to have a direct inhibitory effect on
the osteoclast.

To substantiate the direct mechanism, CT receptors

have been identified on the rat osteoclast in
salmon CT (Warshawsky et al., 1980).

using

125

r

labelled

Within minutes of administration

of CT to isolated osteoclasts, morphological changes have been exhibited (Chambers and Magnus, 1982).

Anderson et al. (1982) have shown CT

specifically affects carbonic anhydrase activity, and Hunter et al.
(1988) have demonstrated a general reduction in cellular acidity in
response to CT. Akisaka and Gay (1986) demonstrated detachment of the
osteoclast from the bone surface with CT-inhibited Na+,K+·ATPase
activity localized in the ruffled border.

In osteoclasts, CT acts by

inhibiting cell movement and membrane ruffling (Baron and Vignery,
1982).

The effects of the hormone on mature osteoclasts either PTH-

stimulated or unstimulated are profoundly inhibitory, however a transient nature of the inhibitory effect on bone resorption in vitro, a
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phenomenon termed escape, has been documented (Raisz et al., 1967;
Wener et al., 1972; Tashjian et al., 1978; Feldman et al., 1980).
These investigators suggested the escape mechanism may be due to a
change in responsiveness to CT of the bones themselves.

When CT and

PTH are administered to bone organ cultures a reduced number of osteoclasts and reduced

45

Ca release was observed within the first 24 hours.

However, after another 24 hours, the values for both parameters recovered to an elevated level similar to cultures treated with PTH alone
(Feldman et al., 1980; Tashjian et al., 1978).

The transient inhibi-

tion may be at the level of recruitment and fusion.
The inhibitory effects of CT on bone resorption have been well
documented, although CT has also been shown to influence bone formation.

The hormone has been localized in rat and mouse osteoblasts

(Morel et al., 1985; Boivin et al., 1987).

Using a demineralized bone

matrix implant as a model for chondrogenesis and osteogenesis, CT
promoted osteogenesis if administered during the initial phases of bone
formation due to increased proliferation of cartilage and bone precursors.

However, when CT was administered after the onset of osteogen-

esis, subsequent bone formation was suppressed (Weiss et al., 1981).

Local Control of Bone Cell Function
Regulation of bone function as previously described has been of
systemic origin.

More recently, attention has been turned to the sub-

ject of local control by cytokines.

Cytokines are soluble proteins

produced by a variety of cells that can modulate the activity of the
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cells that produce them and other cells.

The effects of cytokines in

bone became apparent after the number of osteoclasts was increased in
rat bone organ cultures treated with a factor produced by mitogenactivated peripheral blood mononuclear cells (Horton et al., 1972;
Raisz et al., 1975).

Originally thought to be one factor, it was

determined that osteoclast activating factor (OAF) is a family of
cytokines that possess OAF activity, including interleukin-1 (IL-1),
the most potent, tumor necrosis factor-a (TNFa), and TNF-s.
IL-1 has been shown to be a potent stimulator of bone resorption
in two organ culture systems, the fetal rat long bone system and the
neonatal mouse calvariae system.
quantified by

45

Bone resorption in both assays is

ca release into the medium from prelabelled bones.

both assays system,

45

In

ca release increased with increasing concentra-

tions of IL-1 (Dewhirst et al., 1987; Sato et al., 1986; Gowen and
Mundy, 1986; Heath et al., 1985).

Bone resorption occured in response

to IL-1 in organ culture systems, but not when isolated osteoclasts
were treated with IL-1 (Thomson et al., 1986).

IL-1 stimulated

isolated osteoclasts only when osteoclasts were cultured with osteoblasts, osteoblast-like cells or the supernatant of stimulated osteoblasts.

Like other mediators of osteoclastic bone resorption, IL-1

stimulation of osteoclasts occurs indirectly.

IL-1 has also been shown

to have synergistic bone resorptive effects with PTH and other cytokines (Stashenko et al., 1987; Dewhirst et al., 1987; Lorenzo et al.,
1988).

This synergistic response between cytokines or the combination

of cytokine and hormone suggests complex regulation is mediated by both
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local and systemic factors.
In pathologic conditions that feature chronic inflammation, such
as rheumatoid arthritis and periodontal disease, increased bone resorption occurs.

Horton et al. (1972) proposed the possibility that infil-

trating immune cells release cytokines that act locally and stimulate
bone resorption.

More specifically, Gowen et al. (1983) suggested a

role for IL-1 in the pathogenesis of inflammatory disorders in which
large numbers of monocytes/macrophages are present at osteolytic sites.
IL-1 has been detected in the joint effusions from patients with
rheumatoid arthritis where pathological bone loss occurs (Miyasaka et
al., 1988).

IL-1 may play a critical role in both physiological and

pathological bone loss.
Two other cytokines that stimulate and inhibit bone resorption
repectively are TNF and

interferon~

.

TNF-a and TNF-8 have been shown

to stimulate osteoclastic bone resorption along with the inhibition of
bone formation in the fetal rat long bone and neonatal mouse calvariae
(Bertolini et al., 1986; Deitrich et al., 1976).

As was the case with

IL-1, stimulation of bone resorption by TNF is indirect (Thomson et
al., 1987).

Interferon-y does not possess OAF activity and has been

shown to inhibit both hormone and cytokine stimulated bone resorption
(Gowen et al., 1986).
Growth factors have also been shown to be possible mediators of
bone cell development and/or function.

Transforming growth factors

(TGF)s, which had originally been described as factors that induce neoplastic changes on normal cells, have been shown to affect bone cell
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function.

TGF-S stimulates bone resorption, DNA and collagen synthesis

in cultures of fetal rat calvariae (Centrella et al., 1986) and collagen synthesis and alkaline phosphatase in rat osteosarcoma cells
(Pfeilschifter et al., 1987).

TGF-s~like

activity is produced by bone

and released during the resorption process (Pfeilschifter and Mundy,
1987).

Release of TGF-S during resorption and its stimulatory effects

on osteoblasts, indicate TGF-S may play a role in the coupling of bone
formation to resorption.

The Origin of the Osteoclast
The osteoclast can be distinguished from osteogenic bone cells
not only by its morphology but also by its origin.

A variety of

experimental methods, including parabiosis and transplantation of bone
marrow and spleen cells, have indicated the local mesenchymal origin of
osteogenic cells and the extraskeletal origin of the mononuclear
precursors that fuse to form multinucleated osteoclasts (Gothlin and
Ericsson, 1973; Walker, 1975; Marks and Schneider, 1978, 1982).

The

identity of the precursor has not yet been definitely established
although three possible precursors have been proposed.

The oldest

theory is that the monocyte or macrophage are the direct precursors.
Various studies have demonstrated labelled osteoclasts after labelling
peripheral blood leukocytes (Fischman and Hay, 1962; Jee and Nolan,
1963).

Zabonin-Zallone et al. (1984) have also shown fusion of iso-

lated monocytes with multinucleated cells in 5 day cultures of isolated
osteoclasts.

However, there are significant differences between osteo-
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clasts and monocytes and macrophages.

Macrophages, monocytes and

multinucleated phagocytes do not exhibit the hallmark characteristic of
osteoclastic bone resorption, namely the ruffled border (Kahn et al.,
1978; Rifkin et al., 1979).

Osteoclasts lack the characteristic

membrane receptors, Fe and C3, and specific surface antigens characteristics of the mononuclear phagocyte lineage (Hogg et al., 1980; Horton
et al., 1984, 1985a, 1985b).

Recent organ culture studies indicate

that osteoclasts will develop from precultured bone marrow mononuclear
phagocytes only in the presence of live bone and will resorb only live
bone whereas devitalized bone is most likely resorbed by macrophages
which are able to multinucleate in response to a number of stimuli
(Burger et al., 1984).

Also infusions of macrophage or monocyte/

macrophage precursors are incapable of restoring osteoclastic bone
resorption in osteopetrotic mutants (Schneider and Byrnes, 1983;
Schneider and Relfson, 1988).

The monocyte/macrophage would therefore

be an unlikely candidate for the osteoclast precursor.

Burger et al.

(1982) have recently shown that only the young, proliferating, weakly
adherent mononuclear cells from the bone marrow can differentiate into
osteoclasts.

Their conclusion was monoblasts or promonoblasts are the

more likely candidates for precursor to the osteoclast.
The last possible theory is that the hemopoietic stem cell gives
rise to a separate differentiation line.

This is based on the inabil-

ity murine and human osteoclasts to interact with antibodies specific
for monocytes and granulocytes (Loutit and Nisbet, 1982; Horton et al.,
1984, 1985a, 1985b).

Also, transplantation of normal pluripotent
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hemopoietic stem cells into a histocompatable osteopetrotic recipient
resulted in removal of the excess bone characteristic of osteopetrosis
and the production of phenotypically normal osteoclasts (Schneider et
al., 1986).

The Osteoclast and the Mononuclear Phagocyte System
The osteoclast, because of a putative common lineage and
functional and morphological similarities, has been closely associated
with the cells of the mononuclear phagocyte system (MPS).

The MPS is

composed of hemopoietic precursor cells, promonocytes, circulating
monocytes and tissue macrophages and their derivatives including macrophage polykaryons (van Furth et al., 1972).

Macrophage polykaryons or

multinucleated giant cells (MGC) are commonly found at inflammatory
sites.

They are formed by fusion of mononuclear phagocytes and they

may possess from 2 to more than 200 nuclei.

Two types of giant cells

can be identified based on nuclear arrangements, however they may be
variant phases of the same cell.

The foreign body giant cell (FBGC)

type has nuclei dispersed throughout its cytoplasm while the Langhans
type exhibits a circular or semicircular arrangement of nuclei around
the cell periphery (Chambers, 1978). The cell types are not specifically responsive to particular agents and both can be observed at the same
inflammatory site.

Mariano and Spector (1973) observed both cell types

in response to subcutaneously implanted glass coverslips.

Initially,

only foreign body giant cells were observed but by 7 days the Langhans
cells were more frequently seen.

Cytochemical and ultrastructural
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analysis of the Langhans cell revealed increased levels of acid
phosphatase and succinic dehydrogenase and a highly developed Golgi
apparatus as compared to FBGCs.

A general morphological profile

includes oval euchromatic nuclei, abundant cytoplasm, lysosomes and
plasma membrane ruffling.

Cells of the MPS and osteoclasts are con-

cerned with the removal of biological matter and are equipped with the
necessary organellar machinery needed to accomplish their function
(Chambers, 1978).

From a phylogenetic point of view, the mononuclear

phagocyte and its derivatives are a primitive form of defense.

Compar-

atively, the osteoclast is a relatively new cell, developing with the
evolution of the internalized bony skeleton.

Cells of the MPS perform

critical roles such as phagocytosis and antigen presentation in immune
and foreign body responses.
tion in this manner.

The osteoclast has not been seen to func-

However, mononuclear phagocytes have been shown

to have osteolytic capacity.
The possible role of the mononuclear phagocyte in the process of
bone resorption has recently become apparent.

Monocytes and macro-

phages are often seen at the sites of rheumatoid arthritis, periodontal
disease, and tumors that metastasize to bone.

Although osteoclasts are

principally responsible for physiological bone resorption, mononuclear
phagocytes may also function directly in bone resorption, or indirectly
by stimulating osteoclastic activity.

Organ culture studies using

fetal rat long bones indicated the products of resorbing bones have a
chemotactic effect on human blood monocytes (Mundy et al., 1978).
Evidence has also been presented to substantiate the direct ability of
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phagocytes to degrade devitalized bone in vitro (Kahn et al., 1978;
Mundy et al., 1977; Teitelbaum et al., 1979).

Kahn et al. (1978) have

shown that the resorbing monocytes develop osteoclastic characteristics, clear zones and the release of acid phosphatase at the bone-cell
interface.

Fallon et al. (1983) showed macrophage polykaryons exhib-

ited an increased osteolytic capacity compared to their mononuclear
counterparts.

They proposed the fusion of cells has a physiological

significance which in osteoclasts and macrophage polykaryons, is
directly related to bone resorption.

Another study substantiating the

ability of mononuclear cells to resorb bone in vitro indicated an
increase in

45

ca release with the administration of !.:_ coli lipopoly-

saccharide to bone cultures but no effect with PTH or CT, indicating
the mononuclear activity was modulated by inflammatory mediators and
not by osteotropic hormones (McArthur et al., 1980).

Rifkin et al.

(1980) reported similar results in cultures of fetal rat long bones.
Mononuclear cells were capable of osteoid ingestion and this ingestion
was unaffected by administration of inhibitors of osteoclastic resorption.

In vitro studies using monocytes obtained from patients suf-

fering from juvenile rheumatoid arthritis exhibited significantly
greater

45

Ca release from cultured calvariae when compared to normal

age-matched patients (Key et al., 1986).

These studies indicate the

possible involvement of monocytes in the bone degradation process of
rheumatoid arthritis.

Mononuclear phagocytes and their derivatives may

play an essential, direct and independent role in the physiological
and/or pathological processes of bone resorption.
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Although there is no direct evidence of monocyte or macrophage
fusion to form osteoclasts or a relationship between multinucleated
phagocytes and osteoclasts, the putative ontogenic relationship and
morphological and functional similarities between these cells have
provided a basis for the use of macrophages, monocytes and multinucleated phagocytes in studies of osteoclastic bone resorption (Teitel(baum and Kahn, 1979).

However, along with the similarities that

exist, there are important differences between osteoclasts and the
cells of the MPS that prohibit the use of macrophages, monocytes and
multinucleated phagocytes as osteoclast surrogates in experimentation.
The ability of mononuclear and multinuclear phagocytes to degrade bone
matrix may suggest a role, separate and distinct, from the osteoclast
in the normal versus the pathological processes of bone resorption.

The Ectopic Bone Implant System
Implantation or transplantation of live mineralized bone or
devitalized, demineralized bone at an ectopic site has become a common
model system for osteogenesis, or bone formation (Reddi and Huggins,
1972). The effect of the substrate specificity became apparent with the
development of an in vivo implantation model for bone resorption using
devitalized, mineralized bone matrix (Glowacki et al., 1981).

Devital-

ized, mineralized bone matrix which was implanted into calvarial defects or a subcutaneous site resulted in a rapid response of cellmediated bone resorption.

Histological evaluation of the implant site

revealed mononuclear and multinuclear phagocytes surrounding the bone
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particles.

Functional analysis indicated bone removal had occurred.

Therefore, the mineral content of the implant determines the initiation
of either bone resorption or bone formation and may have clinical
implications in reconstructive or corrective surgery where bone implants are readily used.

In the calvarial defect model, the elicited

cells seen may have migrated from the neighboring bone but in the
subcutaneous model the implant is isolated from the normal bone cell
populations.

Although it is proposed that the multinucleated giant

cells surrounding the bone surface are indeed osteoclasts (Glowacki et
al., 1981; Glowacki and Cox, 1986; Glowacki et al., 1986), similar
studies are not able to substantiate these results and characterize
these cells as multinucleated giant cells or macrophage polykaryons
(Walters and Schneider, 1985, 1987, 1988; Dvonch and Schneider, 1986;
Popoff and Marks, 1986).
at inflammatory sites.

Multinucleated giant cells are commonly found
Chronic inflammation or granulomatous inflam-

mation is a response induced by infective agents, foreign bodies or
physical irritants.

These responses, characterized by a collection of

mature mononuclear phagocytes, result because of the persistent and
often particulate nature of the foreign body or irritant that has
resisted destruction by an acute inflammatory reaction.

In this model

system the particulate and indestructable nature of the bone implant
may provoke a granulomatous inflammatory response.

Therefore, further

investigation is needed to characterize these multinucleated giant
cells at the site of the implant before this subcutaneous bone implant
can be used as a model for osteoclastic bone resorption or monocyte/
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macrophage bone destruction.

CHAPTER I l l

QUANTIFICATION OF TARTRATE RESISTANT ACID PHOSPHATASE
ACTIVITY USING A COMPUTERIZED IMAGE ANALYSIS SYSTEM

ABSTRACT

Tartrate resistant acid phosphatase (TRAP) is a hydrolytic
enzyme that has been associated with bone resorption and has been
accepted as a marker for identification of osteoclasts.

The ease with

which this enzyme can be demonstrated, combined with specific morphological features, creates a quick method for identifying osteoclasts in
normal, pathological and experimental conditions.

Recently, the speci-

ficity and reliability of the enzyme as a marker has been questioned
since other cells have been shown to express TRAP.

In this study I

have developed a method for quantitating TRAP using an image analysis
system and have identified a level of the enzyme specific to osteoclasts which can be used to differentiate osteoclasts from other cells
capable of TRAP expression.

TRAP expression characteristic to the

osteoclast was compared with that expressed by multinucleated giant
cells (MNGC)s recruited to the site of subcutaneously implanted mineralized bone matrix.

Two weeks post-implantation, the pellets were re-

moved and processed for the demonstration of TRAP along with rat proximal tibiae.

Using image analysis, the density and distribution of the
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enzyme could be determined.

A high level of TRAP was consistently

expressed by the in situ osteoclasts.

The MNGGs associated with the

mineralized bone implants expressed little if any TRAP reaction product.

TRAP levels from the mineralized implant associated MNGGs were

significantly different (p< 0.05) from the level of expression by
tibial osteoclasts.

Using this system, the amount of TRAP reaction

product or any other enzyme reaction product expressed can be objectively and reproducibly quantitated.

In this investigation, I have

developed a method which identified a high level of TRAP expression
specific to the osteoclast and this can be used to differentiate
osteoclasts in other normal and experimental situations.
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INTRODUCTION

Tartrate resistant acid phosphatase (TRAP) has been widely
accepted as a cytochemical marker for the osteoclast and its precursors
(Scheven et al., 1986; van de Wijngaert and Burger, 1986; van de
Wijngaert et al., 1987; Hammerstrom et al., 1971).

The presence of the

enzyme and other morphological features like multiple nuclei and the
cell's location along the bone surface allow for quick and easy identification of the osteoclast in the normal microenvironment of bone.
TRAP is relatively specific for osteoclasts but the enzyme has been
identified in osteoblasts, osteocytes, hairy cells, alveolar macrophages and activated macrophages in normal and pathological states
(Bianco et al., 1987;1988; Cole and Walters, 1987; Ketchum et al 1985;
Efstratiadis et al., 1985; Razdun et al., 1983; Snipes et al., 1986).
Osteoclasts are not a product of macrophage or osteoblast fusion and
the presence of TRAP in macrophages, macrophage derived multinucleated
giant cells (MNGC)s or osteoblasts is probably not an indication of
their ability to differentiate into osteoclasts.

Morphological and

histochemical similarities between the osteoclast and MNGCs and/or
macrophages may create problems in identification of osteoclasts in
experimental systems where both may be present.

The precise function

of TRAP is unknown but it is a hydrolytic enzyme related to the process
of bone resorption.
In an attempt to study the ontogeny, behavior and function of
the osteoclast, in vitro and in vivo model systems have been developed
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which employ TRAP as a means of osteoclast identification.
vitro systems have been extensively studied.

Two in

In the first system,

--------

periosteal free, 17 day old fetal metatarsals from the mouse, which do
not develop osteoclasts on their own, can serve as a live substrate to
induce development of osteoclasts when cocultured with osteoclast
precursors (Burger et al., 1982).

In this model system osteoclasts and

their immediate mononuclear precursors have been identified using TRAP
and morphological critieria.
In a second popular in vitro model system, large multinucleated
cells, originally thought to be osteoclasts were generated in long term
cultures of bone marrow mononuclear cells.

These cells were presumed

osteoclasts based on multiple nuclei, morphology and presence of TRAP
(Ibbotson et al., 1984; Roodman et al., 1985; Takahashi et al., 1987).
It has recently been questioned whether these cells are osteoclasts or
MNGCs, since both can be generated in these cultures (Fuller and
Chambers, 1987; Hattersley and Chambers, 1989).

Whether or not osteo-

clasts can be generated in these cultures is not questioned but whether
all MNGCs that are generated are osteoclasts.
Other than transplant studies using mutant animals (Schneider
and Byrnes, 1983; Schneider, 1985; Marks and Schneider, 1978), there
are few models for the study of osteoclasts in vivo.

Subcutaneous

implantation of devitalized, mineralized bone particles, which was
originally thought to elicit a MNGC response after 12 days, more
recently has been proposed as a system to elicit osteoclasts (Glowacki
et al., 1981; Glowacki et al., 1986; Glowacki and Cox 1986).

Others
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believe the response is not osteoclastic but an inflammatory response
eliciting foreign body giant cells

(Walters and Schneider, 1985, 1988;

Holtrop et al., 1982; Popoff and Marks, 1986; Schmitz et al, 1986).

In

some of these investigations TRAP was employed to aid in proving or
disproving the presence of osteoclasts.

In a study by Glowacki et al.,

(1986) not only was the presence of TRAP in MNGCs adjacent to bone
particles, polyetheyline particles and polymethylmethacrylate particles
acknowledged, but the intensity of the reaction product was scored.
Walters and Schneider (1988) also scored and compared the intensity of
TRAP expressed by osteoclasts and MNGCs elicited by subcutaneously
implanted bone and suture.

These were the first attempts to use the

level of TRAP reaction product expressed to characterize a cell.

The

purpose of this investigation was to devise a method to objectively and
reproducibly quantitate and compare the levels of TRAP expression in
multinucleated giant cells elicited by a mineralized bone implant and
in situ osteoclasts.

By quantitating the level of TRAP expression, the

level of intensity characteristic of the osteoclast may be determined.
This quantitation of TRAP is a more specific marker than the presence
or absence of the enzyme.

MNGCs other than osteoclasts may express

TRAP but the level of TRAP expression may differ from that of the
osteoclast.
analysis.

This is the first attempt to standardize the method of
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MATERIAL AND METHODS

Animals:

These studies were performed using Norway-hooded Long Evans

rats (Harlan Labs, Indianapolis, IN).

All animals were maintained and

used according to the recommedations in the Guide for the Care and Use
of Laboratory Animals and the Guidelines of the Institutional Animal
care and Use Committee at Loyola University Medical Center.

Mineralized bone implant:

Tibiae and fibulae were removed from 4-8 wk

old Norway-hooded Long Evans rats.

The soft tissue and cartilagenous

epiphyses were removed and the marrow cavities were flushed with distilled water.

The cleaned diaphyses were washed overnight in distilled

water then extracted with absolute ethanol (30 min) and anhydrous ether
(30 min).

The bones were dried, pulverized with a mortar and pestle

and sieved to yield particles 75-250 um in diameter.

Sterile water was

added to samples to create cohesive pellets of bone particles that
could be easily implanted subcutaneously.

The pellets were air dried

and sterilized by U.V. radiation.

Implants:

Five wk old male Norway-hooded Long Evans rats (n=6) were

anesthetized with chloral hydrate (400 mg/kg).

Dorsal, upper thoracic

incisions were made bilaterally and subcutaneous pockets were created.
Each animal received a bone implant.
treated with betadine.

The incisions were sutured and

Two wks post-implantation, the animals were

sacrificed via ether inhalation, and the implants were carefully
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excised.

A 3 wk old rat was also sacrificed and the proximal tibia

removed.

Mophological and Histochemical

Analyse~:

The implant and a sample of

proximal tibia were immediately fixed in cold 2.5% glutaraldehyde,
0.1 M cacodylate buffer (pH 7.2) with 7% sucrose for 3 hrs, dehydrated
in ascending concentrations of cold acetone and embedded in JB-4.
Three micron sections were cut and allowed to adhere to gel-coated
slides in the cold for 5 days.

Tartrate resistant acid phosphatase

activity was demonstrated using the Cole and Walters (1986) technique
and 50 mM (L+) tartaric acid, however, the samples were not decalcified.

Control sections were incubated without substrate.

Twenty

cells from each of sample were analyzed.

Image Analysis of TRAP: The level of intensity of the TRAP reaction
product in multinucleated giant cells located along the bone surface
was analyzed using a computerized imaging system.

The image was col-

lected using a Dage MTI 68 series video camera attached to the Leitz
Orthoplan 2 light microscope.

The image was processed using the Colo-

rado Video digitizer 270A and Priceton Gamma Tech (PGT) Imagecraft
System 4+, run on a Digital Equipment Systems PDPll/73 using PGT
Imagecraft (Figure 1).

The sections were examined and the field of

interest was displayed on a television monitor (Figure 2).

To ensure

overall consistency, a wire mesh grid was used as a standard to create
a reproducible range of intensity and contrast which would include the
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scale range of reaction product and background.

Inconsistencies

in the counterstained background of the samples were further corrected
by standardizing the background in each sample to the intensity of
mineralized bone.

Using samples of implants and tibia, the lowest

level at which TRAP reaction product that could be detected was used as
a starting point to establish 4 gray level ranges of TRAP reaction product intensity.

On the 256 gray level scale, high intensity reaction

product(+++), composed level 0-100; moderate intensity reaction product(++), composed level 102-150; low intensity reaction product(+),
151-175 and absence of reaction product (0), 175-256.

Computer

generated colors were assigned to each of the pixel ranges (Figure 3).
This color tablet was stored and used on all images.

An image of the

field in view was collected and displayed on the computer screen.

Area

fraction analysis based on this gray-scale palette was limited to the
specific window containing the MNGC (Figure 4 & 5).

A ratio of the

percentages of the gray scale windows, generated by area fraction
analysis was used to determine the final score for each cell.

Cells

were scored as expressing high levels (++), moderate levels (+) or
absence of reaction product.

If the percentage of the TRAP reaction

product that scored for moderate intensity (gray level range 102-150)
was l.5x more than the percentage of the TRAP reaction that scored for
low intensity (gray level range 151-175), the cell was scored as high
intensity.

If the cell failed to meet these requirements, the cell was

scored as moderate intensity.

If the cell exhibited a percentage of

less than 1 in the low intensity range (151-175), the cell was scored
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as absence of reaction product.

The cell was scored as very high

intensity if the percentage value for the high intensity range (0-100)
was Sx the moderate intensity percentage (102-150).

All tibial

osteoclasts exhibit a very high to high level of reaction product (+++
or ++) and these ranges were combined.

Multiple linear comparisons

within the implant group and with the tibial osteoclasts were performed
using the Welsch's t'W test for multiple linear comparisons (Wilcox,

1987).
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RESULTS

Active osteoclasts from the proximal tibia were identified as
multinucleated cells exhibiting vacuolization of the cytoplasm adjacent
to the bone surface.

Tartrate resistant acid phosphatase reaction

product was observed as red granules within the cells and extracellular
staining of the bone matrix adjacent to the osteoclasts (Figure 6).
All osteoclasts consistently exhibited the highest staining intensity.
Each implant was surrounded by a fibrous connective tissue capsule.

At the site of the mineralized implant, large multinucleated

cells were found in contact with the bone particles.

The majority of

the multinucleated cells in contact with the bone particles expressed
either a low level of TRAP reaction product or absence of the enzyme
(Figure 7).

The average number of MNGCs from the implant group

expressing high levels of TRAP was significantly different (p<0.05)
than the average number of osteoclasts expressing high levels of TRAP
the proximal tibiae (Figure 8).

The enzyme was generally distributed

throughout the cytoplasm but in some cells TRAP was localized along the
bone apposed cell membrane.

There was also a low level of nonspecific

extracellualr staining that could easily be distinguished from
intracellular reaction product.

Other MNGCs that were present at the

site and not in contact with bone particles also expressed low levels
of TRAP.

These cells were not analyzed.

The enzyme expression in the

population of MNGCs from the mineralized implants analyzed was
significantly lower than the osteoclasts (Figure 8).
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DISCUSSION

This study describes a technique to assess the level of TRAP
activity and localization in MNGCs and osteoclasts using digital analysis.

The presence of TRAP has contributed to the identification of

osteoclasts in the normal microenvironment of bone and in experimental
model systems which have been used to study bone resorption and osteoclast development and function (Burger et al., 1982; Walters and
Schneider 1988; Glowacki et al., 1986; Ibbotson et al., 1984).

The

level of acid phosphatase activity and TRAP in particular, has been
evaluated to determine the best fixation and demineralization procedures and effects of various concentrations of inhibitors on various
acid phosphatase positive cells (Liu et al., 1987; Hammarstrom et al.,
1971).

Recently, in studies on bone resorption, the level of TRAP

activity in MNGCs has been analyzed to indicate a difference between
MNGCs and osteoclasts.

Both Walters and Schneider (1988) and Glowacki

et al. (1986) evaluated the level of TRAP in MNGCs recruited to subcusubcutaneously implanted bone and other substances.

In the investi-

gation by Walters and Schneider (1988), TRAP activity in MNGCs elicited
by bone and suture implants was scant and differed from the high levels
expressed by tibial osteoclasts.

Glowacki et al. (1986) claimed that

MNGCs elicited to devitalized bone implants were seen with high levels
of TRAP activity suggesting these MNGCs were osteoclasts.

The TRAP

activity in cells from the bone implant however, was not compared to in
situ osteoclasts from bone.

Each study was a subjective analysis of
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TRAP activity.

Regardless of the level of TRAP activity needed for a

cell to be identified as an osteoclast, error may result in the reproducible quantitative assessment of enzyme activity by an observer.

In

this investigation, the level of TRAP expression by the MNGCs from the
mineralized bone implant was significantly different from the TRAP
expressed by osteoclasts.

The morphology of the MNGCs was also

nonosteoclastic, (data not shown), indicating the cells elicited by the
mineralized bone implants were not osteoclasts.
In the system described here, levels of activity, which comprise
a specific catagory defined by the investigator, are set and analysis
is objective and reproducible.

The image of the field of interest is

collected and can be analyzed immediately or saved for future analysis.
Images can be saved and displayed simultaneously with other fields for
comparison.

This system allows for detection of the enzyme intensity

related to distribution.

Ultrastructurally, acid phosphatase has been

localized within the extracellular channels of the ruffled border of
the osteoclast, the bone·cell interspace and the underlying degraded
matrix (Lucht 1971; Doty and Schofield 1972).

In this study TRAP was

also localized in the bone apposed cytoplasm and extracellularly on the
bone surface.
Area fraction analysis can be performed on an entire digitized
image or any part which is enclosed in a window.
limited to the MNGC is analyzed.

A window which is

The area of the window closely

approximates the area of the cell so that the percentages of gray level
intensities corresponding to TRAP reaction product are only those from
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the cell.

This, however, was a close approximation since the shape of

the cells is variable.

For the type of analysis in this investigation,

if a window could have been drawn enclosing a specific area dictated by
the shape of the cell, analyzing the entire cell and no other part of
the field would be ensured.
This method of analysis may be applied to other investigations
where analysis of intensity and distribution of reaction product is
necessary.

The specificity of TRAP to the osteoclast may need to be

redefined in terms of the level of intensity expressed, especially in
experimental model systems where other cells are capable of TRAP
expression and multinucleation.

Although 4 catagories were established

in this study, the availability of 256 gray levels allows for more
catagories consisting of smaller ranges and more specific levels of
analysis.

The established catagories however, were able to distinguish

between levels of TRAP activity expressed by osteoclasts and implantelici ted MNGCs.

TRAP is demonstrated using a variety of substrates and

tissue preparation methods, although this analysis system would not
standardize the method of demonstration it may standardize the method
of assessment so that future investigations using similar techniques
may be compared.
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Figure 1.
Computerized image analysis system for the quantification of
intracellular TRAP reaction product.
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A - Dage MTI 68 series video camera
B - Leitz Orthoplan 2 light microsope
C - General Electric model 4MV-09 video monitor
D - Colorado Video Inc. video digitizer 270A
E - Princeton Gamma Tech System 4+
Princeton Gamma Tech Imagecraft Software
Digital Equipment Corp. PDP 11 /73 computer
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Figure 2.
Digitized image of rat proximal tibia stained for TRAP activity.
Osteoclast (arrows) along the bone (b) surface demonstrating
intense reaction product.

Figure 3.
Color enhanced image of rat proximal tibia from Figure 2.

Color

enhanced gray level ranges highlight intensity and distribution of
TRAP reaction product within the osteoclasts (arrows).

Figure 4.
Area of analysis is limited to osteoclast by creating a window
around the cell.

Figure 5.
Color assigned gray level ranges (upper left) and histogram of
gray level distribution from which area fraction analysis is
computed.

A numerical value is computed for amount of area

occupied by each gray level range.
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Figure 6.
Section of a 3 week old rat proximal tibia demonstrating
osteoclasts (arrows) along the bone (b) surface stained intensely
with TRAP reaction product.

x400

Figure 7.
Section of mineralized bone implant demonstrating absence of TRAP
reaction product in MNGC (arrows) adjacent to bone particles (b).
x425
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Figure 8.
TRAP expression in MNGCs elicited by mineralized bone implant (2wk
post-implantation) and in situ osteoclasts.

TRAP reactivity

scored as high level(++), moderate level(+), or absence of
reaction product (0).

*,

(mean ±SEM).

significantly different than tibia(++), p<0.05.
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CHAPTER IV

A MORPHOLOGICAL AND HISTOCHEMICAL COMPARISON
OF THE CELLS ELICITED BY
ECTOPIC BONE IMPLANTS AND TIBIAL OSTEOCI.ASTS

ABSTRACT

Pellets of mineralized, demineralized and a composite mixture of
mineralized and demineralized, devitalized bone particles were
subcutaneously implanted on the dorsal body wall of young adult rats.
Two wks post-implantation, the pellets were removed and processed for
histochemical and morphological analyses.
processed for evaluation.

Rat proximal tibia was also

The levels of tartrate resistant acid

phosphatase (TRAP) activity in the multinuceated giant cells (MNGC)
from each of the three implants and osteoclasts were assessed using an
image analyzer.

The osteoclasts from the proximal tibia and the

majority of MNGCs from the demineralized implants demonstrated high
levels of TRAP activity.

MNGCs from the mineralized implants showed

either a low level or absence of TRAP activity.

Most MNGCs from the

composite implants exhibited a low level of TRAP activity, however
there was a population of cells that demonstrated a high level of
reaction product, similar to that seen in the tibia and demineralized
implant.

Morphologically, osteoclasts from the proximal tibia and from
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the osteogenic demineralized implant exhibited ruffled borders.

A

small population of MNGCs from the composite implant also revealed
osteoclastic features.

In summary, MNGCs from the mineralized implant

did not exhibit a level of TRAP reaction product or morphology similar
to osteoclasts, while the majority of cells from the demineralized
implant and a subpopulation of the MNGCs elicited by the composite
implant did demonstrate TRAP expression and morphology similar to
osteoclasts.

The ability to elicit cells expressing osteoclasts at an

ectopic site may be more dependent on the presence of demineralized
matrix than mineralized matrix.
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INTRODUCTION

Subcutaneous or intramuscular implantation of devitalized,
demineralized bone matrix can induce osteogenesis at an extraskeletal
site (Reddi and Huggins, 1972; Urist and Strates, 1970).

The reproduc-

ible sequence of events that occurs in response to the implants is
analogous to endochondral bone formation with new bone formation occurring on days 10-11 and remodelling by osteoclasts, occurring on days
12-18. Implantation of devitalized, mineralized bone matrix or a
composite of mineralized/demineralized matrices at a subcutaneous or
intramuscular site inhibits this inductive ability (Urist and Strates,
1970).

Early studies by Reddi and Huggins (1972) identified multinu-

cleated giant cells, rich in organic acids presumably for mineral
dissolution, at the site of a mineralized matrix implant and proposed
the presence of the mineralized matrix either alone or in combination
with demineralized matrix inhibited osteogenesis.

Resorption of

implanted bone fragments was quantitated by histomorphometry and
radioactive calcium release assays to indicate a cell-mediated osteolytic response did in fact occur (Glowacki, 1982; Walters and
Schneider, 1985).

Whether the osteolytic response was osteoclast-

mediated was questionable.
Implantation of devitalized, mineralized bone into a cranial
defect produced a similar cell-mediated osteolytic response, and the
multinucleated giant cells were identified as foreign body giant cells
(Glowacki et al 1981; Glowacki, 1982; Holtrop et al., 1982).

None of
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the cells were characterized as osteoclasts because they did not
demonstrate a ruffled border, the hallmark morphological feature of the
osteoclast.

It is probable that mononuclear and multinuclear phago-

cytes were responsible for the removal of bone, since in vitro studies
have indicated that monocytes and macrophages are capable of resorbing
devitalized mineralized bone (Mundy et al., 1977; Kahn et al., 1978;
Teitelbaum et al., 1979; McArthur et al., 1980).

In these investi-

gations, mononuclear phagocytes and their derivatives did not exhibit
ruffled borders which are functionally linked to the export of hydrolytic enzymes and the uptake of degraded matrix components.

Teitelbaum

et al. (1979) proposed mononuclear phagocytes internalize and digest
bone particles, a different mechanism of osteolysis than the osteoclastic resorption of bone extracellularly, which would explain the
absence of the ruffled borders in these cells.

Epitheliod and foreign

body giant cells are mildly phagocytic and are seen in contact with the
bone particles giving the impression of an osteoclastic mode of bone
resorption.
Even though osteoclasts were not identified in the ectopic bone
matrix implantation system, it was pursued as a model for the study of
bone resorption (Glowacki, 1982; Glowacki, 1983).

This was in part due

to the lack of model systems to study the osteoclast and the acceptance
of cells of the mononuclear phagocyte system as surrogates because of
their presumed common, if not direct, lineage (Kahn et al., 1978;
Teitelbaum et al., 1979).

Since these investigations a decade ago, a

number of differences have been demostrated between cells of the mono-

53

nuclear phagocyte system and osteoclasts (Chambers and Magnus, 1982;
Horton et al., 1984; Hogg et al., 1980).

Because of these differences

and improvements in isolation techniques, the surrogate studies were
abandoned and the osteoclast itself is used for study.

The in vivo

bone implant model however, was not abandoned and in a later study
Glowacki and Cox (1986) generated osteoclasts that demostrated tartrate
resistant acid phosphatase and ruffled borders.

Other investigations

have not substantiated these results (Walters and Scheider, 1985, 1988;
Popoff and Marks, 1986).

Therefore, there is conflicting evidence on

the nature of the multinucleated giant cells (MNGCs) recruited to the
subcutaneously implanted mineralized bone particles.

In this investi-

gation, I have examined the morphology and level of TRAP expressed by
the multinucleated giant cells recruited to devitalized mineralized,
demineralized and a composite of mineralized/demineralized matrices
implants 2 weeks post-implantation, and compared the elicited cells to
osteoclasts from rat proximal tibia.
The purpose of this investigation is to assess the ability of
each of these three implants to generate osteoclasts that are similar
in morphology and expression of TRAP to normal osteoclasts found in the
proximal tibia.

Although the implant composed of both mineralized and

demineralized bone matrices is unable to induce osteogenesis the presence of both matrices may have an effect directly or indirectly on
osteoclast recruitment.

Not only will the presence or absence of TRAP

be evaluated, but also the intensity of the reaction product, to further discriminate between the high level of TRAP expressed by function-
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al osteoclasts and the low level of TRAP that has previously been
demonstrated in multinucleated giant cells generated at the site of
bone and suture implants (Walters and Schneider, 1988).

If the multi-

nucleated giant cells recruited to the mineralized bone particles, in
fact are osteoclasts, they should resemble in situ osteoclasts from the
proximal tibia.
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MATERIAL AND METHODS

Animals
These studies were performed using Norway-hooded Long Evans rats
(Harlan Labs, IN).

All animals were maintained and used according to

the recommedations in the Guide for the Care and Use of Laboratory
Animals and the Guidelines of the Institutional Animal Care and Use
Committee at Loyola University Medical Center.

Bone Powder Preparation
Mineralized bone implant:

Tibiae and fibulae were removed from 4-8 wk

old Norway-hooded Long Evans rats.

The soft tissue and cartilagenous

epiphyses were removed and the marrow cavities were flushed with distilled water.

The cleaned diaphyses were washed overnight in distilled

water then extracted with absolute ethanol (30 min) and anhydrous ether
(30 min).

The bones were dried, pulverized with a mortar and pestle

and sieved to yield particles 75-250 um in diameter.

Sterile water was

added to samples to create cohesive pellets of bone particles that
could be easily implanted subcutaneously.

The pellets were air dried

and sterilized by ultraviolet (U.V.) radiation.

Demineralized bone implant:

The mineralized bone powder prepared above

was treated with 0.5 N HCl, 25 meq/gm (demineralizing agent) for 3 hrs.
followed by repeated washings of cold deionized water to thoroughly
remove the acid, absolute ethanol (30 min) and anhydrous ether (30
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min).

Sterile water was added to samples of demineralized bone to

create pellets.

The pellets were air dried and sterilized by U.V.

radiation.

Composite implant:

A mixed bone powder implant was created from 25 mg

mineralized bone powder and 5 mg demineralized bone powder.

Sterile

water was added to the mixture of the two powders to create cohesive
pellets which were air dried and sterilized by U.V. radiation.

Implants
Six 5 wk old male Norway-hooded Long Evans rats were anesthetized with chloral hydrate (400 mg/kg).

Dorsal, upper thoracic

incisions were made bilaterally and subcutaneous pockets were created.
One bone powder pellet was placed in each subcutaneous pocket and the
incisions were sutured and treated with betadine.
one of each of the three types of bone implants.

Each animal received
Two wks. post-

implantation, the animals were killed via ether inhalation, and the
implants were carefully excised.

Morphological and Histochemical Analyses
One half of the specimen was immediately fixed in 4.0% glutaraldehyde, 0.1 M cacodylate buffer (pH 7.2) for 24 hrs, post-fixed in 1%
osmium tetroxide, dehydrated in ascending concentrations of ethanol,
and embedded in Epon 812.

One micron sections were cut and stained

with toluidine blue and evaluated by light microscopy.

Thin sections
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(60-70 run) were cut and stained with uranyl acetate and lead citrate
for ultrastructural analysis using the Hitachi H600 electron microscope.
The remaining half of each specimen was immediately fixed in
cold 2.5% glutaraldehyde, 0.1 M cacodylate buffer (pH 7.2) with 7%
sucrose for 4 hrs, dehydrated in ascending concentrations of cold
acetone and embedded in JB-4.

Proximal tibiae were removed from 3 wk

old Norway black-hooded Long Evans rats and also prepared as above.
Three micron sections were cut and allowed to adhere to gel-coated
slides in the cold for 5 days.

Alternate sections were stained for

tartrate resistant acid phosphatase activity using 50 mM L(+)-tartaric
acid or for mineral content using the von Kossa technique (Humason,
1962).

Tartrate resistant acid phosphatase activity was demonstrated

using the Cole and Walters (1986) technique but sections were not
calcified.

Control sections were incubated without substrate or

without tartaric acid.
evaluated.

Twenty MNGC from each of the samples were

The level or intensity of the TRAP reaction product in

rnultinucleated giant cells located along the bone surface was analyzed
using the computerized imaging system, Princeton Gamma Tech (PGT)
lmagecraft System 4+ run on a Digital Equipment Systems PDP 11/73, and
PGT lmagecraft software (Figure 1).
detail in Chapter III.

The technique is described in

Comparisons of the average number of cells

expressing high TRAP activity were made among the three implant types
and the tibia.

Multiple linear comparisons among the implant groups

and tibiae were performed using the Welch's t'W test for multiple
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linear comparisons (Wilcox, 1987).
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RESULTS

Active osteoclasts from the proximal tibia were identified as
multinucleated cells exhibiting vacuolization of the cytoplasm and a
striated border adjacent to the bone surface (Fig. 2a).

At the ultra-

structural level, osteoclasts were identified by ruffled borders limited by an organelle free, clear zone and a highly vacuolated area adjacent to the ruffled border (Figure 2b).

Tartrate resitant acid phos-

phatase reaction product was observed as red granules within the cells
and extracellular staining of the bone matrix adjacent to the osteoclasts (Figure 2c).

All osteoclasts consistently exhibited the highest

TRAP staining intensity.
Each implant was surrounded by a fibrous connective tissue capsule.

At the site of the mineralized implant, large multinucleated

cells were found in contact with the bone particles.

Some cells exhib-

ited vacuolization at the bone surface, but most cell-bone contacts
were unremarkable (Figure 3a,b).

The cell membrane adhered to the

particle surface and often extended processes into the irregularities
on the surface.

The non-bone apposing surface of the cells exhibited

cytoplasmic folds, often quite elaborate.

The nuclei were present most

often in a linear arrangement, at a random distance from the boneapposed cell surface.

The majority of the multinucleated cells in con-

tact with the bone particles expressed either a low level of TRAP
reaction product or absence of the enzyme (Figure 3c).

The number of

MNGCs from the mineralized implants expressing high level of enzyme
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expression was significantly different from the osteoclasts from the
tibia and demineralized implants and MNGCs from the composite implants
(p<O.OS) (Figure 4).
Large multinucleated cells were present at the osteogenic site
of the demineralized bone particle implant.

The osteogenic site or

area of mineral deposition was determined using the von Kossa technique
and only the MNGCs at that site were analyzed.

The cells were not as

large as those seen in the mineralized implant and did not surround the
bone particles but were present at discrete sites on the newly mineralized bone surface (Figure Sa).

The ultrastructure of the cell mem-

brane in contact with the particle exhibited extensive infoldings bound
by smooth organelle-free areas (Figure Sb).
infoldings was an area of vacuolization.

Adjacent to the membrane

Rough endoplasmic reticulum

and mitochondria were the most abundant organelles.

These cells were

similar to the osteoclasts of the proximal tibiae in both morphology
and TRAP expression (Figure

4, Sb).

Almost all MNGCs expressed high

levels of TRAP reaction product intracellularly. Weak extracellular
staining was noticed in areas of adjacent bone also had extracellular
TRAP staining.
The composite implant recruited a population of multinucleated
cells similar in size, morphology and expression of TRAP reaction
product to those recruited to the mineralized implant.

These large

multinucleated cells were found in contact with the mineralized
particles (Figure 6a).

A small population of the MNGCs demonstrated

clear zones and infoldings of the cytoplasm along the

bone-appo~ed
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surface (Figure 6b).

A population of cells which expressed heavy

amounts of TRAP reaction product was also present along the mineralized
particles (Figure 6c).

These cells were located in discrete areas

within the implant site, and concentrated the enzyme in the area of the
cell adjacent to the bone.

These cells were not as large and had fewer

nuclei, compared to the majority of MNGCs exhibiting low levels of TRAP
reaction product.

Ultrastructural examination revealed the majority of

MNGCs made contacts with the mineralized matrix particles but showed no
membrane specializations except occasional clear zones or
tion.

vacuoliza~

The majority of cells exhibited moderate to no TRAP reactivity

with a small subpopulation exhibiting high levels of reaction product
(Figure 4).

The number of cells exhibiting a high level of TRAP

expression was significantly different from the number of MNGCs from
the mineralized, demineralized or tibial osteoclasts, (p<0.05).

The

lack of osteoblasts and the lack of patchy von Kassa staining, which is
characteristic of newly mineralized bone, indicated osteogenesis had
not occurred.
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DISCUSSION

Tartrate resistant acid phosphatase and the specific morphological features associated with bone resorption allow for the characterization and discrimination of the osteoclast from the remaining population of bone cells responsible for matrix deposition and maintenance
and cells of the mononuclear phagocyte system, specifically the macrophage polykaryon which exhibits some similar morphological features.
In the present study, these two parameters, TRAP activity and morphology, were used to evaluate cells generated at the sites of subcutaneously implanted bone matrix.

The osteoclasts from the proximal tibiae

exhibited ruffled borders and clear zones in contact with the bone surfaces and were consistantly heavily stained with TRAP reaction product.
TRAP has been isolated from bone (Andersson et al., 1984, 1986; Anderson and Toverud 1979; 1982) and is generally accepted as a cytochemical
characteristic of the osteoclast (Minkin, 1972; Hammerstrom et al.,
1971; 1983) and its mononuclear precursors (Baron et
Wijngaert and Burger, 1986).

al., 1986; van de

The remaining populations of bone cells,

mononuclear phagocytes and virtually all other cells except erythrocytes express primarily, the tartrate sensitive form of acid phosphatase.

Recent studies have shown that rat osteoblasts and osteocytes at

or near the growth plate express low levels of punctate cytoplasmic
TRAP reactivity (Bianco et al., 1988; Cole and Walters, 1987).

Limited

expression of the enzyme by these cells and the sensitivity to tartrate
by other cells in the bone microenvironment allow TRAP to be used as a
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tool for identification of osteoclasts.
other cells can express TRAP.

In some pathological states,

Bianco et al. (1987) reported that in

disease states where macrophage hypersensitivity is expected like,
chronic granulocyte leukemia and metastasis of carcinoma in the bone
marrow, a large proportion of bone marrow macrophages express TRAP
activity.

Bianco et al. suggested the expression of the enzyme may be

due to immunologically mediated activation and that TRAP expression in
cells of the mononuclear phagocyte system may be a marker of cell
activation.

In an in vitro study, Razdun et al. (1983) reported stimu-

lated monocytes exhibited TRAP activity and concluded that expression
of TRAP activity may indicate macrophage differentiation.

In this

investigation, the ability of the MNGCs to express low levels of TRAP
activity may reflect a stimulated or activated state as in the above
cited studies.
The number of MNGCs that express a level of TRAP activity and
morphology similar to that of osteoclasts increased with an increase in
the amount of demineralized matrix in the subcutaneous bone implant.
The mineralized implant generated MNGCs that expressed weak TRAP activity and no ruffled border-a response similar to a chronic inflammatory
response.

A chronic stimulus results in an infiltration of mononuclear

phagocytes which differentiate into epitheloid cells and fuse to form
MNGCs (Adams et al., 1976).

At 14 days the particles were surrounded

by mononuclear and MNGCs which have been shown to be osteolytic or less
specifically, able to digest foreign substances including mineralized
matrix (Walters and Schneider, 1985; Glowacki, 1982).

This indicates
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the implantation of mineralized matrix does not create an osteolytic
response that is mediated by osteoclasts but does create an inflammatory response that is osteolytic.

Popoff and Marks (1986) supported

this conclusion and reported implant generated MNGCs were morphologically distinct from osteoclasts.

Walters and Schneider (1988),

implanting chips of mineralized bone, reported 52% of bone induced MNGC
were mildly TRAP positive and differed considerably from that observed
in osteoclasts.
Glowacki and Cox (1986) however, reported MNGCs surrounding
mineralized bone particles stained for TRAP activity and expressed
osteoclast morphology. In the initial qualitative study, MNGCs with
osteoclastic morphology and TRAP reactivity were described.

The level

of TRAP activity in comparison to active osteoclasts or MNGCs was not
described.

In a subsequent study (Glowacki, 1988), the MNGCs surround-

ing mineralized bone particles from composite implants of bone and
polyethylene or polymethylmethacrylate were quantitated for levels of
TRAP activity and shown to stain strongly or very strongly compared to
MNGCs adjacent to plastic particles but again they were not compared to
in situ osteoclasts. Our work does not support these findings.

Acid

phosphatase and enzymes in general, may be altered by tissue processing
(Burstone, 1958).

The use of 2.5% glutaraldehyde in this study instead

of 2.0% paraformaldehyde used in the Glowacki studies, may have decreased the intensity of the enzyme reaction product.

However, when

compared to tibial osteoclasts fixed in the same manner, the relative
difference remains and the MNGCs from the mineralized implant still
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demonstrate a lower level of activity.
The osteoclast is a highly specific cell which has been shown to
be under strict control of a variety of cytokines and hormones, both
directly and indirectly.

The substrate, mineralized bone, and mechan-

ism of action are specialized.

Although the mononuclear phagocyte and

its derivatives have osteolytic capabilities among its repetoire, the
osteoclast does not share in a wide range of capabilities of the macrophage.

Implantation of mineralized bone presents the required sub-

strate for osteoclasts but indicates by their absence, that all
requirements for the generation of osteoclasts have not been met.
Implantation of demineralized bone served as a control for
generation of osteoclasts at an ectopic site since implantation of
demineralized bone matrix initiates a highly reproducible sequence of
events that leads to bone formation and subsequent remodelling by
osteoclasts (Reddi and Huggins, 1972).

In this investigation, deminer-

alized bone matrix was subcutaneously implanted and at 14 days, the
majority of MNGCs expressed intense reaction product and osteoclast
morphology.

In the demineralized implant, osteoclasts are present at

an ectopic site, but only where osteogenesis had been initiated.
Recruitment of osteoclasts seems to be dependent on (1) the early
stages of chemotaxis, chondogenesis and osteogenesis and (2) formation
of a mineralized matrix.

Burger et al (1984) co-cultured bone marrow

mononuclear phagocytes with live mineralized, periosteum and osteoclast-free fetal bone rudiments and reported that the activity of
skeletal cells was a prerequisite for osteoclast recruitment. .Rodan
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and Martin (1981) also suggested that osteoblasts may be mediators of
osteoclast activity and need to be present.

Implantation of deminer-

alized bone has most frequently been used to study the initial phases
of osteogenesis however it can also be used to study recruitment of the
osteoclasts and the initial phases of bone remodelling.
Approximately 2/3 of the MNGCs elicited from the mixed implant
exhibited moderate to no TRAP reactivity and macrophage-derived MNGC
morphology, which was similar to the population profile from the
mineralized implant.

However, the remaining 1/3 of the total MNGCs

population sampled, exhibited high levels of enzyme reactivity and
osteoclast-like features.
demineralized implant.

Osteogenesis was not occurring as in the

Reddi and Huggins (1972) first reported the

inability of a mixed sample of demineralized bone and bone ash to
induce osteogenesis.

They reported the presence of osteoclastic giant

cells which had blocked the transformation of fibroblasts and subsequent bone formation.

This cell response from the composite implant is

similar to the mineralized implant but the subpopulation of MNGCs that
resemble osteoclasts makes it unique.

The most obvious reason for the

unique response is the presence of the demineralized bone matrix.
Although osteogenesis was not occurring, the presence of demineralized
bone may have had an impact either directly on osteoclast recruitment
or indirectly by affecting cells at the site which stimulate recruitment or expression of the osteoclast phenotype.

The mineralized matrix

may impair the full expression and matrix producing function of the
differentiating progenitor cell although, these cells still may be able
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to provide the appropriate signals for osteoclast precursor recruitment
and differentiation.

The highly TRAP positive cells were not distrib-

uted uniformly throughout the implant but were present in discrete
areas which may indicate a localized response within different parts of
the implant.

The osteoclast-like cells were most often found adjacent

to the mineralized particles which indicates a preference for a mineralized substrate.

If the response to stimulate osteoclast-like cells

can be augmented in the mixed implant, or if the recruitment and/ or
expression of the osteoclast phenotype could be stimulated in the
mineralized implant, these may be feasible in vivo models for the study
of osteoclast function at a nonskeletal site.
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Figure 1.
Color enhanced digitized image composite of 4 MNGCs (arrows)
adjacent to bone (b), representing the 4 levels of TRAP reaction
product intensity (a, no reaction product; b, low intensity; c,
moderate intensity; d, high intensity).

Figure 2.
a.

Scattered multinucleated osteoclasts (arrows) from rat
proximal tibia, present along the trabeculae of bone (b).
x413

b.

Electron micrograph of multinucleated osteoclast surrounding
bone (b).

Hallmark morphological features of ruffled border

(arrows) and clear zone (arrow heads) are demonstrated.

Note

smooth appearence of bone surface associated with clear zone
(area of attachment) and rough appearance of bone surface
under ruffled border (area of resorption).
c.

x3719

Osteoclasts (arrows) from rat proximal tibia containing high
concentrations of TRAP reaction product. (bone,b)

x400
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Figure 3.
MNGCs elicited by the mineralized bone implant, 2 wks.
post-implantation:
a.

MNGCs (arrows) surrounding mineralized bone particles (b).
x272

b.

Stained for TRAP reactivity, MNGCs (arrows) in contact with
the bone surface (b) exhibit mild reaction product.

c.

x425

Electron micrograph of MNGC in contact with a mineralized
surface.

x7500

71

72

Figure 4.
TRAP expression in MNGCs elicited by mineralized, demineralized
and composite bone matrix implants (2 wks. post-implantation) and
situ osteoclasts.

TRAP reactivity scored as high level(++),

moderate level (+) or absence (0) of reaction product. (mean ±SEM)
a. mineralized (++) significantly different than tibia
(++), p<0.05.

b. mineralized (++) significantly different than
demineralized (++), (p<0.05.
c. mineralized (++) significantly different than composite
(++), p<0.05.
d. demineralized (++) significantly different than
composite (++), p<0.05.
e. composite (++) significantly different than tibia (++),
p<0.05.
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Figure 5.
Osteogenic response elicited by implantation of demineralized bone
matrix, 2 wks. post-implantation:
a.

Active multinucleated osteoclasts contacting newly
mineralized bone matrix (b).

b.

x640

Electron micrograph of osteoclast exhibiting a ruffled
border (rb), in contact with the bone surface (b).

c.

x6000

Osteoclasts stained intensely with granular TRAP reaction
product. (bone,b)

x413

7'5
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Figure 6.
MNGCs elicited by a composite implant, 2 wks. post-implantation:
a.

MNGCs (arrows) surrounding bone particles (b).

b.

MNGC in contact with bone particles (b) demonstrating
membrane specialization at areas of contact.
contact is unlike that seen in Fig. 3b.

c.

x272

Cell-bone

x6000

MNGCs (arrows) in contact with bone particles (b), stained for
TRAP reactivity.

Note the range of TRAP reaction product

concentrations in MNGCs.

x264
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CHAPTER V

THE EFFECTS OF INTERLEUKIN 2 INFUSION
ON CELLS ELICITED BY ECTOPIC BONE IMPLANTS

ABSTRACT

Investigations into the effects of interleukin 2 (IL-2) on bone
cell functions are limited. Based on the hypothesis of immune-bone cell
interactions, the ability of IL-2 to stimulate bone resorption has been
tested in vitro and the results are conflicting (Gowen and Mundy, 1986;
Ries et al., 1989).

In an attempt to further analyze the effects of

IL-2 on bone cell function, human rIL-2 (3 x 10

4

U/day) was infused at

the site of 3 types of subcutaneous bone implants (mineralized, demineralized and a composite mixture of both types).

Implantation of

pulverized mineralized bone matrix elicits an inflammatory response
while a demineralized bone implant elicits an osteogenic response and a
composite implant elicits an inflammatory response with a minor population of cells exhibiting osteoclastic characteristics.

Tartrate

resistant acid phosphatase (TRAP) and ultrastructural analyses were
used as criteria to assess whether IL-2 could stimulate differentiation
of these cells at the site into osteoclasts or modulate the cells at
the site of the implants to express the osteoclast phenotype.

Multinu-

cleated cells elicited by the IL-2 treated mineralized implants exhib-
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ited weak TRAP activity and no osteoclastic features. There was no
change in the multinucleated cells elicited by the IL-2 treated mineralized implants compared to control.

Osteoclasts from the treated and

control demineralized implants demonstrated high levels of TRAP activity and osteoclastic morphology. The osteogenic response seemed to be
enhanced by IL-2.

An increase in the number of highly TRAP positive

multinucleated cells and cells exhibiting clear zones and ruffled borders was present in the IL-2 treated composite implants versus controls, however the increases were not significant.

From these implant

studies, it has been shown that IL-2 has no effect on the inflammatory
multinucleated cells elicited by the mineralized implant and it was
unable to promote osteoclast differentiation or expression. In the
demineralized, IL-2 may have an effect on bone cell function recognized
by an enhancement of the osteogenic response.

IL-2, like other

cytokines, may have a profound direct or indirect effect on bone cell
function.
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INTRODUCTION

Cytokines, as local mediators of bone cell function, have
recently been shown to play an integral role in the complex functions
of bone formation, growth, remodelling and repair in health and disease. One means by which the relationship between the immune and skeletal systems has been recognized is through the study of osteopetrosis,
a congenital disease resulting in accumulation of bone matrix.

Func-

tional defects in both immune cells and osteoclasts have been shown
which may be the result of a common defect in development since immune
cells and osteoclasts are of hemopoietic origin.

Transplantation of

bone marrow or splenocytes has been shown to cure the disease in some
mutant rodents (Walker 1975; Ash et al., 1980; Schneider 1985).

Anoth-

er aspect of the relationship between the immune system and the skeletal system is the modulatory effects of immune cell products on bone
cell function. An effect was first recognized when products of mitogenactivated peripheral blood mononuclear cells stimulated bone resorption
by increasing the number and function of osteoclasts in bone organ
cultures (Horton et al., 1972).

Osteoclast activating factor, as it

was first described, has now been characterized as a family of cytokines including interleukin-1 (IL-1) and tumor necrosis factors (TNF a)
and (TNFS ).

These stimulators of bone resorption may function in both

health and disease.

In chronic inflammatory diseases such as rheuma-

toid arthritis and periodontitis, the infiltrating immune cells release
products that may contribute to osteolysis and tissue destruction.
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Analysis of joint fluid taken from patients with rheumatoid arthritis
indicate the presence of osteoclast activating factors (Nouri et al.,
1984b; DiGiovani et al., 1988; Saxne et al., 1988).
Cyclosporin A is a potent immunosuppressive agent that is
frequently used to control graft rejection after organ transplant surgery.

Among a number of effects, it has been shown to inhibit T-cell

proliferation and activation, B-cell differentiation, and secretion of
cytokines (specifically IL-1 and IL-2) (Thomson et al., 1984; Bunjes et
al., 1981). Cyclosporin has also been shown to inhibit normal bone
resorption in vivo (Orcel et al., 1989) and parathyroid hormone,
prostaglandin E , 1,25-dihyroxyvitamin
2

o3

and osteoclast activating

factor induced resorption of fetal rat limb bones in vitro (Stewart et
al., 1986; 1989).

It seems possible that the inhibitory effects on

bone resorption may be an indirect effect of suppressed immune cell
activity. Normal bone cell function may be dependent on normal immune
system function.
The effects of isolated cytokines on bone have been evaluated in
vitro and have been shown to have a variety of effects.

The conclu-

conclusions from these investigations however, may not address the
complex interactions and profound indirect effects of cytokines, the
immune cells that produce them, systemic hormones and bone cell function.

Interleukin 2 (IL-2) is one such cytokine that may have a com-

plex indirect mechanism of action. IL-2 was first functionally described as thymocyte stimulating factor due to its ability to enhance
the thymocyte mitogenic response to phycohemagglutinin and concanavalin
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A (Morgan et al., 1976).

It is also able to regulate the production of

cytokines (Numerof et al., 1988; Nedwin et al., 1985), play a role in
wound healing (Barbul et al., 1986) and act as an antineoplastic agent
in cancer therapy (Rosenberg et al., 1985; Lotze et al., 1986).

IL-2

therapy produces toxic side effects including fever, hypotension, increased plasma acute-phase proteins and increased stress-related pituitary hormones (Mier et al., 1988; Mier et al., 1987).
Investigations into the effects of IL-2 on the skeleton are
limited.

Based on the premise that other immune cell products may

contribute to osteoclast activating factor activity, Gowen and Mundy
(1986) tested IL-1, IL-2 and interferon-y for their activity in the
mouse calvarial resorption assay.
resorption.

IL-2 failed to stimulate bone

In a similar study by Ries et al. (1989), IL-2 was shown

to stimulate osteoclastic activity by increasing acid production and
45 ca 1 cium
.
re 1 ease.

Other studies have focused on the role of IL-2 in

the connective tissue destruction of chronic inflammatory conditions,
including rheumatoid arthritis.

Elevated levels of IL-1 and IL-2 in

the joint fliud of patients with rheumatoid arthritis have been reported (Nouri et al., 1984a; Nouri et al., 1984b).

The effects of this

cytokine on bone cell function or its mechanism of action, whether
direct or indirect, are unknown.

IL-2 does seem to indicate another

link between the immune and skeletal systems.
A system that may evaluate the effects of IL-2 in vivo is the
subcutaneous bone matrix implant model.

Implantation of pulverized

mineralized matrix produces a chronic inflammatory response that is
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osteolytic but not osteoclastic.

Using the presence of tartrate

resistant acid phosphatase (TRAP) and ultrastructural morphology of the
osteoclast as criteria, the ability of IL-2 to stimulate the differentiation of osteoclasts at this ectopic site can be evaluated.
Implantation of a demineralized matrix produces an osteogenic response.
The effects of IL-2 on the promotion of an osteogenic site and subsequent osteoclastic activity can be evaluated using this demineralized
matrix implant.

A composite of both mineralized and demineralized bone

matrix has been shown to generate a large population of non-osteoclastic multinucleated giant cells and a small population of osteoclast-like cells.
evaluated.

The effects of IL-2 on these populations will be
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MATERIAL AND METHODS

~imals

These studies were performed using Norway-hooded Long Evans rats
(Harlan Labs, IN).

All animals were maintained and used according to

the recornrnedations in the Guide for the care and use of Laboratory Animals and the Guidelines of the Institutional Animal Care and Use
Committee at Loyola University Medical Center.

Bone Powder Preparation
Mineralized bone implant:

Tibiae and fibulae were removed from 4-8 wk

old Norway-hooded Long Evans rats.

The soft tissue and cartilagenous

epiphyses were removed and the marrow cavities were flushed with distilled water.

The cleaned diaphyses were washed overnight in distilled

water then extracted with absolute ethanol (30 min) and anhydrous ether
(30 min).

The bones were dried, pulverized with a mortar and pestle

and sieved to yield particles 75-250 um in diameter. Sterile water was
added to samples to create cohesive pellets of bone particles that
could be easily implanted subcutaneously.

The pellets were air dried

and sterilized by ultraviolet (U.V.) radiation.
Demineralized bone implant:

The mineralized bone particles prepared

above were treated with 0.5 N HCl, 25 meq/gm (demineralizing agent) for
3 hrs followed by repeated washings of cold deionized water to
thoroughly remove the acid, absolute ethanol (30 min) and anhydrous
ether (30 min).

Sterile water was added to samples of demineralized
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bone to create pellets.

The pellets were air dried and sterilized by

u.V. radiation.
Composite implant:

A composite bone particle implant was prepared from

25 mg mineralized bone powder and 5 mg demineralized bone powder. Sterile water was added to the bone particle mixture to create cohesive
pellets which were air dried and sterilized by U.V. radiation.

IL-2 Administration
Human rIL-2 was administered by constant infusion at a dose of 3
x 10

4 U/day for 14 days (Piquet et al., 1986). Infusion of rIL-2 at the

site of the bone implants was acheived by subcutaneous implantion of
the Alzet osmotic minipump (Alzet Corp., Palo Alto, CA; model 2002) at
the site.

Human rIL-2 was kindly provided by Hoffmann-LaRoche, Nutley,

N.J. rIL-2 and was diluted in 0.9% NaCl, 5.0 mg/ml mannitol and 75 mg/l
ml SDS; the control rats received pumps loaded with vehicle only.

Implants
Five wk old male Norway-hooded Long Evans rats were anesthetized with chloral hydrate (400 mg/kg).

Dorsal, upper thoracic inci-

sions were made bilaterally and subcutaneous pockets were created. One
pocket was extended anteriorly and medially.

The bone powder pellets

were placed in the subcutaneous pockets, one pellet placed as far
anteriorly as possible, in the cervical region; the remaining two pellets were placed in the left and right scapular regions.
received one of each of the three types of bone implants.

Each animal
A third
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midline, lower thoracic incision was made in each animal and a subcutaneous pocket was created anteriorly.

An Alzet minipump was inserted

into the pocket, with the delivery outlet in the vicinity of the three
bone implants thus concentrating the cytokine at the site of the bone
implants.

The incisions were sutured and treated with betadine.

Two

wks post-implantation, the animals were sacrificed via ether inhalation, and the implants and proximal tibia were carefully excised.

The

minipumps were removed and analyzed for proper delivery.

Morphological and Histochemical Analyses
One third of the specimens and a sample of proximal tibia were
immediately fixed in 2.5% glutaraldehyde, 0.1 M cacodylate buffer (p.H.
7.2) for 48 hrs., post-fixed in 1% osmium tetroxide, dehydrated in
ascending concentrations of ethanol, and embedded in Epon 812.

One

micron sections were cut and stained with toluidine blue and evaluated
by light microscopy.

Thin sections (60-70nm) were cut and stained with

uranyl acetate and lead citrate for ultrastructural analysis using the
Hitachi H600 electron microscope.
Another third of each specimen and samples of proximal tibia
were immediately fixed in cold 1% paraformaldehyde, 0.1 M cacodylate
buffer (pH 7.2) with 7% sucrose for 3 hrs, dehydrated in ascending
concentrations of cold acetone and embedded in JB-4.

Three micron

sections were cut and allowed to adhere to gel-coated slides in the
cold for 5 days.
tase.

The sections were then stained for alkaline phospha-

Alkaline phosphatase was demonstrated using Burstone's complete
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media (Pearse, 1968) containing Napthol AS-BI phosphate as a substrate
and Red-violet LB diazonium salt as the capture agent in 0.1 M Trizma
buffer,(pH 8.5). The substrate was omitted from control media.
The remaining third of each specimen and samples of proximal
tibiae were stain for tartrate resistant acid phosphatase activity
using 50 mM L(+)-tartaric acid, and a modified Cole and Walters (1986)
technique (samples were not decalcified), or for mineral content using
the von Kossa technique. Control sections were incubated without substrate. The level or intensity of the TRAP reaction product in multinucleated giant cells located along the bone surface was assessed using
the PGT System 4+ image processor, DEC PDP 11-73, and PGT Imagecraft
software.

The cells were catagorized into 3 groups according to the

level of TRAP expression.

All tibial osteoclasts exhibit a high to

moderate level of reaction product (+++ or ++) and these ranges were
combined.

The IL-2 treated cell population profiles were compared to

the controls for each of the three implant types and the tibiae.
Comparisons of the number of cells expressing high levels of TRAP reaction product were also made among the implant groups and the tibiae.
Multiple linear comparisons among the three implant groups and tibial
osteoclasts were performed using the Dunn-Bonferroni t-test and the
Welch's t'W test for multiple linear comparisons (Wilcox, 1987).
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RESULTS

Active osteoclasts from the proximal tibia in both IL-2 treated
and controls were identified as multinucleated cells exhibiting vacuolization of the cytoplasm adjacent to the bone surface.

Tartrate

resistant acid phosphatase reaction product was observed as red granules within the cells and extracellular staining of the bone matrix
adjacent to the osteoclasts.

All osteoclasts consistently exhibited

the highest staining intensity.

At the ultrastructural level, osteo-

clasts were identified as multinucleated cells with ruffled borders
limited by an organelle free, clear zone along the bone surface and a
highly vacuolated area adjacent to the ruffled border.
Each implant was surrounded by a fibrous connective tissue
capsule.

At the site of the mineralized implant, large multinucleated

cells were found in contact with the bone particles.
ing indicated the particles were mineralized.

Von Kassa stain-

Some cells exhibited

vacuolization of the membrane at the bone surface, but most cell-bone
contacts were unremarkable (Figure la).

The cell membrane adhered to

the particle surface and often extended processes into the irregularities on the surface.

The non-bone apposing surface of the cells

exhibited cytoplasmic folds, often quite elaborate.

The majority of

the rnultinucleated cells in contact with the bone particles expressed
either a low level of TRAP reaction product or absence of the enzyme
(Figure lb).

Other MNGCs that were present at the site and not in

contact with bone particles also expressed low levels of TRAP.

These
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cells were not quantitated.
phatase.

No cells were stained with alkaline phos-

The enzyme expression in the population of MNGCs analyzed was

significantly lower than the osteoclasts (p<.05) but there was no
difference in control mineralized implant versus IL-2 treated mineralized implant (Figure 2).
Large multinucleated cells were present at the osteogenic site
of the demineralized bone particle implant.

The osteogenic site or

area of mineral depositon was determined using the von Kossa technique
and by the presence of alkaline phosphatase containing cells.
MNGCs in that site were analyzed.

Only the

The cells were not as large as those

seen in the mineralized implant and did not surround the bone particles
but were present at discrete sites on the newly mineralized bone surface.

The ultrastructure of the cell membrane in contact with the

particle exhibited extensive infoldings bound by smooth organelle-free
areas (Figure 3a).
vacuolization.

Adjacent to the membrane infoldings was an area of

Rough endoplasmic reticulum and mitochondria were the

most abundant organelles.

These cells were morphologically similar to

the osteoclasts of the proximal tibiae.

In these areas of the implant

almost all MNGCs expressed high levels of TRAP reaction product intracellularly (Figure 3b).

The TRAP expression in the MNGCs from the IL-2

treated and control demineralized implants and tibial osteoclasts was
not significantly different.
The composite implant recruited a population of multinucleated
cells similar in size, morphology and expression of TRAP reaction
product to those recruited to the mineralized implant except for a
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subpopulation of cells exhibiting osteoclastic features (Figure 4a).
The majority of cells exhibited moderate to no TRAP reactivity with a
subpopulation exhibiting high levels of reaction product (Figure 2).
These cells were present on the surface of the bone particles and were
not as large and had fewer nuclei, than the majority of MNGCs exhibiting low levels of TRAP reaction product (Figure 4b).

Image analysis

revealed nonspecific extracellular staining and TRAP concentrated along
the bone-apposed cell surface.

Statistical analysis did not reveal a

significant difference between TRAP expression in the IL-2 treated versus control composite implant however a shift in TRAP expression was
evident.

Von Kassa and alkaline phosphatase staining revealed no evi-

dence of osteogenesis at these implant sites.
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DISCUSSION

The role of IL-2 in these models for osteolysis and osteogenesis
is uncertain. The data indicates osteoclasts were not recruited by
infusion of IL-2 at the implantation site of mineralized bone particles, based on the lack of TRAP expression and osteoclast morphology.
The response to implantation of mineralized bone particles can be
characterized as a chronic inflammatory response.
cytes and monocytes are recruited to the site.

Initially lympho-

The monocytes, macro-

phages and multinucleated giant cells surround the particles and
attempt to degrade them while fibroblasts attempt to isolate the
irritant by proliferating and producing a fibrous capsule.

Lymphocytes

are present during these events and their role which may be significant, is not well defined.

Lymphocytes may act as modulators of macro-

phage and fibroblast activity.

Cytokines, like IL-2, which have a

stimulatory effect on lymphocytes may therefore have an indirect role
in the inflammatory response.
Wound healing, which may be the endpoint of an inflammatory response, has been shown to be significantly augmented by chronic IL-2
administration (Barbul et al., 1986).

One mechanism of action proposed

by the authors is that IL-2 stimulated lymphocytes to release factors
which promote macrophages to produce IL-1.

In this case, IL-1 may

stimulate fibroblastogenesis but in the case of the mineralized bone
implant, it may also stimulate osteolysis.

At 14 day post-implanta-

tion, the osteoclasts from the demineralized implant expressed high
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levels of TRAP reaction product.

There was no significant difference

between the TRAP expressed by the osteoclasts from the experimental and
control demineralized implants indicating that IL-2 did not inhibit the
recruitment or activity of osteoclasts during demineralized matrix induced bone formation.

By 14 days after implantation, the development

of a marrow cavity has begun.

As in normal bone development, bone

cells are in close proximity to the bone marrow cells and specialized
environment.

Infusion of IL-2 may have an effect on the developing

hemopoietic cells.

Chronic administration of IL-2 to osteopetrotic

mutant rats has produced both changes in natural killer cell activity
and bone resorption (Schneider et al., 1988, 1990).
Enhanced bone formation was observed in two samples.

Recently a

study has shown the mitogenic activity of IL-1 for fibroblasts appears
to be indirect and mediated by the platelet derived growth factor
(PDGF)-A chain gene which has a paracrine or autocrine effect (Raines
et al., 1989).

PDGF is member of the growth factor family that is

responsible for regulating the proliferation of connective tissue
cells.

PDGF has been shown to enhance induction of bone formation by

demineralized bone matrix implants (Howes et al., 1988).

Since IL-2

can stimulate the production of IL-1, the accelerated osteogenesis may
be due to IL-1 stimulated PDGF production.

In patients with intra-

abdorninal cancers, IL-2 may be administered directly into the abdominal
cavity by Technokoff catheter.

A side effect of intraabdominal

administration lyrnphokine activated killer (LAK)/IL-2 therapy is
fibrosis.

The fibrosis may be due to cytokines produced by the LAK

93

cells or the induction of cytokines produced by host cells stimulated
by IL-2.

Wound healing factors like TGF-S and PDGF, which may be pro-

duced, could create the fibrosing response which may be similar to the
enhancement of the osteogenic response in the demineralized implant
(Urba et al., 1989).
The composite implant showed a subpopulation with osteoclastlike TRAP expression and morphology whose number increased with IL-2
administration.

From the demineralized bone implant, it was shown that

IL-2 did not inhibit recruitment or osteoclast activity.

IL-2 promoted

osteoclast-like TRAP expression and the morphological features of the
multinucleated giant cells from the mixed implant.

I was unable to

determine if the effect was direct or via the production of other cytokines.

I was also unable to determine from this study if the increase

in the number of cells expressing high levels of TRAP reaction product
and osteoclast-like morphology was due to promoting osteoclast phenotype in cells that had not expressed it previously by recruiting new
cells to the implant site.

Further studies are needed to address the

specific effects of IL-2 on osteoclast function and/or development.
The effects of IL-2 on this chronic inflammatory response was
not evaluated in this investigation but may be significant. Cells
extracted from inflamed periodontal lesions are capable of producing
both IL-2

vitro as assessed by the method of Warren and Pembrey

(1981), and bone resorbing factors, as assessed by calcium release from
cultured mouse calvariae (Seymour et al., 1985).

IL-2 has also been

detected in the synovial fluid of patients with rheumatoid arthritis,
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alkylosing spondolysis and psoratiac arthritis, irnmunoinflarnmatory
diseases and osteoarthritis, a degenerative disease (Nouri et al.,
1984a).

The presence of IL-2 in the synovial fluid of patients with

immunoinflarnmatory disease is not surprising because activated lymphocytes which produce IL-2 are present.

However, the presence of IL-2 in

the joint fluid of osteoarthritics is surprising because few activated
lymphocytes are present.

Regardless of the nature of the disease,

these finding indicate lymphocytes and IL-2 which facilitates their
expansion, may contribute to connective tissue degenerative diseases.
The most relevant effect of IL-2 to this investigation is its
ability to stimulate the expression of cytokines which may play a role
in bone remodelling. Human peripheral blood mononuclear cells (PBMCs)
were induced by recombinant IL-2 to secrete TNF-a and TNF-8 (Nedwin et
al., 1985).

Production of TNF-a and TNF-8 was augmented by combining

IL-2 with recombinant interferon-y (rlNF-Y).
to stimulate the production of IL-la
vitro (Numerof et al., 1988).

IL-2 has also been shown

and IL-18 by human PBMCs in

The results indicated that the 11-1 is

largely derived from direct stimulation of monocytes.
Both TNF and 11-1 have been shown to have effects on bone cell
function.

TNF-a stimulates DNA synthesis which resulted in an increase

number of collagen synthesizing cells, but it has a direct inhibitory
effect on osteoblast function (Canalis, 1987; Centrella et al., 1988).
Bertolini et al. (1986) have demonstrated human rTNF-a and rTNF- B
induced osteoclastic bone resorption in organ cutures of fetal rat
calvariae.

The effects of TNF appear to be mediated by the osteoblast
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(Thomson et al., 1987).

Its ability to stimulate osteoclastic resorp-

tion and its presence in the the synovial fluid from patients with
rheumatoid arthritis provides evidence that TNF-amay play a significant role in connective tissue destruction and more specifically the
pathogenesis of arthritis (Di Giovine et al., 1988; Saxne et al.,
1988).
IL-1 has also been shown to affect both bone formation and
resorption.

Using the calvarial resorption assay, IL-1 has been shown

to stimulate DNA, collagen and noncollagenous protein synthesis but
exposure to IL-1 at high doses or for long periods of time results in
inhibition of collagen synthesis (Canalis, 1987).

Using the osteo-

blastic cell line MC3T3-El, IL-1 S stimulated cell proliferation but
inhibited alkaline phosphatase and collagen synthesis (Ikeda et al.,
1988).

Both studies imply the importance of IL-1 S in the local

regulatory mechanism of bone remodelling. The effects of IL-lS

on

bone formation seem to be secondary to its potent effects on bone
resorption.

Gowen and colleagues have shown that highly purified IL-1

and recombinant IL-1 resorbs bone in vitro (Gowen et al., 1983; Gowen
and Mundy, 1986).

The effect is indirect and mediated by the osteo-

blast (Thomson et al., 1986).

It is now thought that IL-1 is major

constituent of OAF and is 1000 times more potent than TNF (Thomson et
al., 1986).

IL-1 has also been shown to have synergistic effects with

other cytokines and hormones and its role in physiological and pathological bone loss may be significant (Dewhirst et al., 1987; Lorenzo et
al., 1988; Tatakis et al., 1988).
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The use of IL-2 therapy as an antineoplastic agent in cancer
treatment has proveri effective in some cases. It does however, produce
toxic side effects.
investigated.

The effects on the skeleton have not been

In this investigation, it was shown that IL-2 has an

effect on the expression of TRAP and osteoclast morphology.
of IL-2 in bone cell function may be a complex one.

The role

Further investi-

gation into the role of IL-2, both direct and indirect, and the role of
immune cells in the mechanisms of bone formation, growth, and remodelling is needed to further understand relationship between the immune
and skeletal systems.
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Figure 1.
Sections of IL-2 treated mineralized bone implant 2 wks.
post-implantation:
a.

MNGC adjacent to bone particle (b). The MNGC shows no membrane
specializations at the area of contact with the bone surface.
x6500

b.

Mild TRAP reactivity in MNGCs (arrows) contacting the bone
particles (b).

x264
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Figure 2.
TRAP reactivity in MNGCs elicited from mineralized, demineralized
and composite bone implants (2 wks. post-implantation) and
osteoclasts from IL-2 treated (t) and control (c) rats.

TRAP

expression scored as high level(++), moderate level(+), and
absence (0) of reaction product. (mean ±SEM).
a. mineralized (T) (++) is significantly different than
tibia (C) (++)

p<0.05.

b. mineralized (T) (++) is significantly different than
demineralized (T) (++), p<0.05.
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Figure 3.
Sections of IL-2 treated demineralized bone implant:
a.

Multinucleated osteoclast displaying a ruffled border (rb)
at the bone surface (b).

b.

x4875

Osteoclasts (arrows) at the osteogenic site, stained intensely
with granular TRAP reaction product.

(bone,b)

x438
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Figure 4.
Sections of IL-2 treated composite bone implant:
a.

MNGC adjacent to bone (b) demonstrating clear zone (cz) and
ruffled border (rb).

Note the degraded appearance of the bone

surface subjacent to the ruffled border area. x6125
b.

MNGCs (arrows) contacting bone particles (b).

Note the

intensity of the intracellular reaction product along the
area of cell-bone contact.

x413
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CHAPTER VI

THE EFFECTS OF 1,25 DIHYDROXYVITAMIN D ,
3
PARATHYROID HORMONE AND CALCITONIN
ON THE CELLS ELICITED BY ECTOPIC BONE IMPLANTS

ABSTRACT

The nature of the cells recruited to the site of subcutaneously
implanted, devitalized bone matrix are dependent on the mineral content
of the implant. The difference between macrophage derived-multinucleated giant cells (MNGC)s and osteoclasts can be determined on the basis
of morphological features and level of tartrate resistant acid phosphatase (TRAP) expression.

Two wks post-implantation, MNGCs are present

at the site of mineralized bone matrix particles and fail to exhibit
osteoclast morphology or a high level of TRAP, while MNGCs similar to
osteoclasts are present at the site of demineralized and composite
implants.

In an attempt to recruit, stimulate differentiation and

expression of the osteoclast phenotype, or inhibit these effects,
osteotropic hormones, 1,25 dihydroxyvitamin

o3

(l,25(0H) D ) (2.08
2 3

pmoljhr), parathyroid hormone (PTH) (1.24 U/hr) and calcitonin (CT)
mU/hr) were infused locally into the area of 3 types of bone matrix
implants. Control animals received the 3 types of bone implants and
vehicle.

Two wks post-implantation, the implants were removed along

with proximal tibiae from each animal and processed for histochemical
105
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and ultrastructural analyses.

The level of TRAP activity in the MNGCs

from each of the three implants and tibial osteoclasts were assessed
using an image analyzer.

No MNGCs from any treated or control miner-

alized groups expressed high levels of TRAP or membrane specializations, characteristic of the osteoclast.

The l,2S(OH) D -treated
2 3

composite implants had more MNGCs expressing higher levels of TRAP
activity compared to controls (p<.05).

There were no changes in TRAP

expression in the PTH or CT-treated composite groups.

Ultrastruc-

turally, both treated and control composite groups showed MNGCs with
osteoclastic morphology. In the PTH stimulated demineralized group, the
demineralized implant was not osteogenic.

There was no difference

between treated and control in the l,25(0H) D and CT treated deminer2 3
alized implants.

In summary, the hormones did not appear to effect the

MNGCs elicited by the mineralized implant since they are probably not
osteoclastic. l,25(0H) D which is thought to exert its effect on imma2 3
ture osteoclasts, in contrast to PTH which stimulates mature osteoclasts, was effective in increasing the number of MNGCs expressing high
level of TRAP in the composite implants.

PTH completely inhibited the

osteogenic process in the demineralized treated implant.

Because of

the presence of inflammatory and osteoclast-like cells in the composite
implant, and its possible cellular modulation by hormones, the
composite implant may be a valuable model for inflammatory bone loss.
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INTRODUCTION

Ectopic bone implant systems have been developed to study both
bone resorption and bone formation using mineralized and demineralized
bone matrix implants, respectively.

Although the response to the

mineralized bone matrix is osteolytic, there is some discrepancy as to
whether the cells responsible for bone removal are osteoclasts.
Glowacki and Cox (1986) claimed osteoclasts, which were identified
morphologically and histochemically, are present 12 days postimplantation.

Walters and Schneider (1985,1987) and Popoff and Marks

(1986), however, dispute this claim and describe the multinucleated
giant cells (MNGCs) as osteolytic but non-osteoclastic, due to lack of
ruffled borders and low tartrate resistant acid phosphatase (TRAP)
activity.

I substantiate these results in this study and in an earlier

investigation (Chapter IV).

The identity of these MNGCs is critical as

to whether this mineralized bone implant system can be used as a model
to study osteoclast function and normal bone remodelling.

Whether

osteoclasts can be found at the site of ectopically implanted
mineralized bone matrix remains in question.
The osteogenic response elicited by demineralized bone particles
is similar to endochondral bone formation, including development of a
marrow cavity at 21 days post-implantation.

Although this model system

has been extensively used to study bone formation, this type of implant
can also be used to study bone remodelling. The fact that osteoclasts
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are recruited to the osteogenic site and are responsible for remodelling the newly mineralized matrix has not been disputed.

Functional

osteoclasts can be elicited at this site however only after the appearance of osteoblasts and the formation of mineralized matrix.

The

osteoclasts present at this implant may be used for comparison to the
MNGCs elicited at the mineralized site.
Although not as extensively investigated, implanting a composite
of mineralized bone matrix and demineralized bone matrix results in the
appearance of MNGCs and a subpopulation of cells which exhibit osteoclastic morphology.

This is a unique response since a population of

cells with osteoclastic characteristics are present without the occurrence of osteogenesis as in the demineralized implant. The ability of
the demineralized matrix to induce bone formation is inhibited, however
it seems to be able to elicit osteoclast-like cells along with the
MNGCs that are elicited by the mineralized matrix.
In this investigation, the relationships between MNGCs and
osteoclasts, the ability of three types of bone matrix implants to
elicit specific populations of cells, and the use of these implants as
models for physiological and/or pathological bone resorption will be
addressed.

Specifically, the MNGCs will be assessed morphologically

for classic osteoclastic features, and histochemically for expression
of TRAP, and compared with multinucleated giant cells and tibial osteoclasts.

TRAP has been proposed as a marker for the osteoclast and its

precursor and can easily be demonstrated (Minkin, 1982; Cole and
Walters, 1987).

A high level of cytoplasmic TRAP expression and the
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morphological feature of the ruffled border provide a quick and easy
method for osteoclast identification and have been extensively used in

--

in vitro investigations (Ibbotson et al., 1984; MacDonald et al., 1987;

Roodman et al., 1985).

Comparison among the MNGCs elicited by each of

the three types of bone implants will reveal morphological and histochemical similarities and differences which are important to determine
which implants can be used for the study of osteoclastic bone resorption.
Hormone infusion will be used to further stimulate or inhibit
the systems to recruit osteoclast precursors and their subsequent
fusion into functional osteoclasts and/or stimulate the expression of
the osteoclastic phenotype and function in the cells already present.
The hormones include parathyroid hormone (PTH) and 1,25 dihydroxyvitamin n

3

(l,25(0H) D ), stimulators of osteoclastic function and
2 3

calcitonin (CT) an inhibitor of osteoclastic function.

The ability of

the cells at the ectopic site to respond to these osteotropic hormones
will provide another means to assess the true nature of their identity.
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MATERIALS AND METHODS

~nimals

These studies were performed using Norway-hooded Long Evans rats
(Harlan Labs, IN).

All animals were maintained and used according to

the recommedations in the Guide for the Care and Use of Laboratory
Animals and the guidelines of the Institutional Animal Care and Use
Committee at Loyola University Medical Center.

Bone Implant Preparation
Mineralized bone implant:

Tibiae and fibulae were removed from 4-8 wk

old Norway-hooded Long Evans rats.

The soft tissue and cartilagenous

epiphyses were removed and the marrow cavities were flushed with distilled water.

The cleaned diaphyses were washed overnight in distilled

water then extracted with absolute ethanol (30 min) and anhydrous ether
(30 min).

The bones were dried, pulverized with a mortar and pestle

and sieved to yield particles 75-250 um in diameter.

Sterile water was

added to 50 mg samples to create cohesive pellets of bone particles
that could easily be implanted subcutaneously.

The pellets were air

dried and sterilized by ultraviolet (U.V.) radiation.

Demineralized bone implant:

The mineralized bone powder prepared above

was treated with 0.5 N HCl, 25 meq/gm (demineralizing agent) for 3 hrs
followed by repeated washings of cold deionized water to thoroughly
remove the acid, absolute ethanol (30 min) and anhydrous ether (30
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min).

Sterile water was added to 10 mg samples of demineralized bone

to create pellets.

The pellets were air dried and sterilized by U.V.

radiation.

Composite bone implant:

A composite bone powder implant was created

from 25 mg of mineralized bone matrix and 5 mg of demineralized bone
matrix.

Sterile water was added to the mixture of the two powders to

create cohesive pellets which were air dried and sterilized by U.V.
radiation.

Hormone Administration
Bovine PTH fragments 1-34 (10,000 U/mg) was purchased from Sigma
Chemical Co., St. Louis, MO.

It was dissolved in a vehicle of 10-

in 0.9% NaCl containing 20 mg/ml cysteine'HCl (Rasmussen, 1959)

3

HCl

and

delivered at a rate of 1.24 U/hr (Obie and Cooper, 1979) (n=4).
l,25(0H) D
2 3
N.J.

was a gift from Dr. Uskokovic at Hoffmann LaRoche, Nutley,

It was dissolved in a vehicle of propylene glycol and delivered

at at rate of 2.08 pmol/hr (Parfitt et al., 1984; Brommage et al.,
1983) (n=5).

Salmon CT (4500 U/mg) was a gift from Dr. J. Bastian at

Armour Chemical Co., Kankakee, IL.

It was dissolved in a vehicle of 1%

gelatin, pH adjusted to 3.2 with concentrated HCl and delivered at a
rate of 42 mU/hr (Bastian et al., 1978) (n=4).

Infusion of the hor-

mones at the site of the bone implants was acheived by subcutaneous
implantation of the Alzet osmotic minipwnp, Model 2002 (Palo Alto, CA)
at an adjacent site.

Control pwnps, containing the appropriate vehi-
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cles, were also prepared for each of the three hormone studies. The
length of infusion was 14 days.

!,!?plants
Five wk old male Norway-hooded Long Evans rats (n=l6) were
anesthetized with chloral hydrate (400 mg/kg).

Dorsal,upper thoracic

incisions were made bilaterally and subcutaneous pockets were created.
One pocket was extended anteriorly and medially.

The bone powder pel-

lets were placed in the subcutaneous pockets, one pellet placed as far
anteriorly as possible, in the cervical region; the remaining two pellets were placed in the left and right scapular regions, respectively.
Each animal received one of each of the three types of bone implants.
A third midline, lower thoracic incision was made in each animal and a
subcutaneous pocket was created anteriorly.

An Alzet minipump,

containing one of the hormones or their respective vehicles, was
inserted into the pocket, with the delivery outlet in the vicinity of
the three bone implants, concentrating the hormone at the site of the
bone implants.

The incisions were sutured and treated with betadine.

Two wks post-implantation, the animals were sacrificed via ether inhalation, and the implants and proximal tibiae were carefully excised.
The minipumps were removed and analyzed for proper delivery.

Morphological and Histochemical Analyses
One third of the implant specimens and samples of proximal tibia
were inunediately fixed in 2.5% glutaraldehyde, 0.1 M cacodylate buffer
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(pH 7.2) for 48 hrs., post-fixed in 1% osmuim tetroxide, dehydrated in
ascending concentrations of ethanol, and embedded in Epon 812.

One

micron sections were cut and stained with toluidine blue and evaluated
by light microscopy.

Thin sections (60-70nm) were cut and stained with

uranyl acetate and lead citrate for ultrastructural analysis, using the
Hitachi H600 electron microscope.
Another third of the specimens and samples of proximal tibia
were prepared for demonstrating alkaline phosphatase activity.

Samples

were immediately fixed in cold 1% paraformaldehyde, 0.1 M cacodylate
buffer (pH 7.2) with 7% sucrose for 3 hrs, dehydrated in ascending
concentrations of cold acetone and embedded in JB-4.

Three micron

sections were cut and allowed to adhere to slides in the cold for 5
days.

The sections were incubated for 60 min in Burstone's complete

media (Pearse, 1968) containing Napthol AS-BI phosphate as substrate
and Red-violet LB diazonium salt as the capture agent in 0.1 M Trizma
buffer (pH 8.5).

Control sections·were incubated without substrate.

The last third of the specimens and samples of the proximal
tibiae were prepared for demonstration of tartrate resistant acid
phosphatase activity using a modified Cole and Walters (1986) method
(sections were not decalcified).

In brief, samples were immediately

fixed in cold 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2)
with 7% sucrose for 3 hr., dehydrated in ascending concentrations of
cold acetone and embedded in JB-4.

Three micron sections were cut and

allowed to adhere to gel-coated slides in the cold for 5 days.

The

sections were stained for TRAP activity using 50 mM L(+)-tartaric acid.
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Control sections were incubated without substrate.

Alternate sections

were stained for mineral content using the von Kossa technique.
The level or intensity of the TRAP reaction product in multinucleated giant cells located along the bone surface was analyzed using a
computerized image analysis system, Princeton Gamma Tech System 4+
image processor, DEC PDP 11/73 and PGT Imagecraft software.
nique is described in detail in Chapter III.

The tech-

Comparisons were made

among the average number of cells expressing different levels of TRAP
activity within each hormone-treated implant type.

Comparisons were

also made between the average number of cells expressing high levels of
TRAP activity for each hormone-treated implant types (mineralized,
demineralized and composite), their appropriate controls and the average number of osteoclasts expressing high levels TRAP from the proximal
tibiae.

Statisitics were performed using the Dunn-Bonferroni t-test

and Welch's t'W test for multiple comparisons (Wilcox, 1987).
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RESULTS

TRAP localization by this technique, results in a granular
red-maroon reaction product nonuniformly distributed throughout the
cytoplasm. Extracellular staining was also noticed along the bone
particles and in the dense connective tissue, often near MNGCs.

No

differences were noticed among the MNGCs from each of the three hormone
control implant groups.

The cells from each control implant group were

similar in morphology and TRAP reactivity indicating the vehicles had
no effect on the parameters analyzed.
The majority of the MNGCs from the mineralized implants exhibited low levels or absence of TRAP reactivity, regardless of hormone
treatment (Figures

1,2,3).

Low level reaction product could be

characterized by a diffuse pink staining throughout the cytoplasm (Fig.
4).

The reaction product was not often seen in granular form.

These

cells were in contact with the bone particles and often elongated in
shape to cover the surface of the particle.

Ultrastructural analysis

revealed the area of the bone-cell interface was unremarkable in terms
of membrane specializations (Fig. 5).

Nuclei were usually linearly

situated, parallel and at a distance from the bone surface.

The

non-opposing cell membranes could be found exhibiting nonspecific
membrane ruffling.
MNGCs stained with intense TRAP activity were found at the
osteogenic site of the demineralized implant.

Areas of osteogenesis

were determined by the presence of cells exhibiting alkaline phospha-
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ease and von Kossa staining for mineralized matrix.
represented the early stages of remodelling.

Fourteen days

There were areas of

developing cartilage and mineralized matrix, which were covered by a
layer of osteoblastic cells or scattered osteoclasts (Fig. 6).

The

osteoclasts were irregular in shape and made discrete contacts with the
mineralized matrix.

The multinucleated cells along with some

mononuclear cells stained strongly for TRAP.

Only the multinucleated

cells in contact with the bone matrix were evaluated (Fig. 7).

In some

cells the reaction product was unevenly distributed and localized in
the cytoplasm adjacent to the areas of bone contact.

Treatment with

l,25(0H) D and CT showed no major changes in development of the
2 3
osteoclasts at this ectopic site. CT seem to be more stimultory in
terms of osteogenesis.

PTH administration however, completely

inhibited osteogenesis and osteoclast development in the demineralized
implant samples.

The PTH treated implants elicited mononuclear cells

with little TRAP activity to the implant site.

MNGCs similar to those

seen at the mineralized site of other implants were not seen.

Half of

the samples from the l,25(0H) n treated animals did not generate an
2 3
osteogenic site. In the l,25(0H) D samples that were osteogenic and CT
2 3
treated demineralized implants, normal bone remodelling occurred.
Ultrastructural analysis of the MNGCs from l,25(0H) n and CT treated
2 3
demineralized implants revealed normal osteoclast morphology.

Cells in

contact with the bone surface exhibited abundant mitochondria, clear
zones and ruffled borders.

The nonopposed surface did not exhibit

intense membrane ruffling as seen in the MNGCs from the mineralized
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implants.
The composite implant was able to elict a mixed population of
MNGCs based on morphological and histochemical criteria.

Von Kossa

staining revealed most MNGCs were in contact with mineralized particles.

Osteogenesis occurred in one l,25(0H) D treated implant and one
2 3

CT treated implant.

In these implants, the MNGCs exhibited intense

TRAP activity and ruffled borders and resembled those from the osteogenie demineralized implants.

Most MNGCs from the hormone-treated

composite implants resembled those from the mineralized implants,
exhibiting little if any TRAP reactivity and no ruffled borders (Fig.
8).

However, a subpopulation, which stained more intensely for TRAP

and exhibited osteoclastic features including ruffled borders were also
present (Fig. 9).

The number of these cells increased significantly

(p<.05) with l,25(0H)

o

2 3

treatment (Fig. 1).

These cells, could be

identified at the light microscopic level, on the basis of smaller
size, discrete contacts with the bone surface and membrane specializations at the bone/cell interface.
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DISCUSSION

This investigation was designed to assess the effects of local
hormone infusion on the morphology and enzyme expression in populations
of multinucleated cells elicited by mineralized, demineralized and
composite bone implants.

Each implant elicited a unique cellular

response, evidently dependent on the presence or absence of mineralized
matrix.

The effects of the hormones on cells elicited by the mineral-

ized implants were of particular interest because infusion of the
stimulators of bone resorption was an attempt to generate osteoclasts
at an ectopic site.

In previous investigations by this and other

laboratories, osteoclasts have not been elicited by mineralized matrix,
as claimed by Glowacki and Cox (1986).

Gowacki and Cox stated the only

stimulus necessary for osteoclast development was the implanted
mineralized matrix.

I do not deny the importance of mineralized matrix

as a stimulator of osteoclast development and function and as the
substrate for these cells.

However, in this investigation, the

presence of the mineralized matrix alone or together with local infusion of either PTH or l,25(0H) D , did not promote the development of
2 3
osteoclasts at the site of ectopically implanted mineralized bone
matrix.

Instead, as documented by the studies of Walters and Schneider

(1985, 1988) and Popoff and Marks (1986) the implanted mineralized
matrix elicited an inflammatory response characterized by the infiltration of osteolytic, non-osteoclastic, slightly TRAP positive MNGCs.

At

the light microscopic level, the location and morphology of these MNGCs
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are similar to those of osteoclasts however, ultrastructurally, ruffled
borders, the hallmark morphological feature of the osteoclast, were not
seen in treated or control implants.
PTH and l,25(0H) D have been shown to stimulate osteoclastic
2 3
formation and function.

PTH-stimulated bone resorption is associated

with increased synthesis and secretion of hydrolytic enzymes including
TRAP and expansion of the ruffled border (Vaes, 1965, 1968; Miller,
1978; Miller et al.,1984).

Like other stimulators of bone resorption,

PTH and l,25(0H) o do not affect the osteoclast directly but are
2 3
thought to act indirectly via the osteoblast (Rodan and Martin, 1981;
Chambers et al., 1985; McSheehy and Chambers, 1986a).

In the mineral-

ized implants the absence of alkaline phosphatase staining indicates
the lack of osteoblasts and osteogenesis at this site.
tiveness of PTH and l,25(0H)
at the site.

o

2 3

The ineffec-

may be due to the lack of osteoblasts

However, it has been shown that other cells like lympho-

cytes, which are present at the site of implantation, have receptors
for these hormones and may play a role as modulator of osteoclast
development and function (Whitfield et al., 1970).
CT has also been shown to be a direct modulator of bone activity, specifically as an inhibitor of osteoclast activity (Nicholson et
al., 1986; Chambers et al., 1986).

Chambers and Magnus (1982) showed

the quiescent effects on isolated osteoclasts and no effects on isolated osteoblasts, peritoneal macrophages or inflammatory giant cells.
By the parameters evaluated, there was no effect of CT on the MNGCs
elicited by the mineralized bone matrix implant.
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The question still remains, are osteoclasts or their precursors
present at the site of the implanted mineralized matrix?

I believe

that osteoclasts are not present and cannot be recruited to this site,
therefore, the hormones would be ineffective in stimulating an increase
in TRAP activity or expression of osteoclastic morphology.

The osteo-

tropic hormones have not been shown to affect non-osteoclastic osteolysis which is characteristic of some inflammatory pathologies
(Chambers and Magnus, 1982).

The data from this investigation indicate

osteoclasts are not present either with or without local infusion of
osteotropic hormones at the site of the mineralized bone implant.
Osteoclasts can be elicited at the site of ectopically implanted
demineralized matrix after the formation of bone. The demineralization
process unlocks the osteoinductive potential of bone morphogenic
protein, which initiates the complex cascade of bone formation (Urist
and Strates, 1970).

Reddi and Huggins (1972) described the osteoinduc-

tive nature of the demineralized bone matrix as transformability,
because the matrix, the factors present in it and/or released by it,
induces fibroblasts to undergo differentiation toward the osteoblast
phenotype.

Osteogenesis does not occur at the site where mineralized

bone is implanted.
The phase of the osteogenic cascade relevant to this
investigation is remodelling.

The implants were removed at 14 days to

correspond to previous studies and to the lifetime of the pumps. The
experiments were designed so that the hormone would be infused from the
time of implantation.

At 14 days, the remodelling phase had just
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begun.

Osteoclasts were present and demonstrated ruffled borders and

intense TRAP activity.

The effect of the hormones was therefore on the

process of osteoclast recruitment and subsequent function.

Mononuclear

TRAP positive cells were present in the area of remodelling and these
cells may be osteoclast precursors.

There was a marked difference in

the multinuclear cells elicited by the demineralized and mineralized
matrices.

The osteoclasts from the demineralized implant were smaller

in size and made discrete contacts with the newly mineralized bone.
This was in sharp contrast to the MNGCs from the mineralized implants
which were large cells that almost totally surrounded the particles.
All osteoclasts from controls, l,25(0H) n and CT treated implants
2 3
exhibited moderate to high TRAP activity and ruffled borders.

1,25

(OH) D and CT have opposing effects on bone resorption, but they may
2 3
have similar, stimulatory effects on bone formation (Parfitt et al.,
1984; Farley et al., 1988; Weiss et al., 1981).

I saw no change in

TRAP activity since the contol osteoclasts were classified at the
highest level.

To determine if a change was present, the scale of

enzyme activity would have to be reevaluated.
The PTH treated demineralized implants failed to generate either
an osteogenic or inflammatory reaction.

Few MNGCs were seen at the

implant site indicating again, the presence or absence of the mineralized matrix had profound effects on eliciting an inflammatory reaction.
PTH has been shown to decrease bone formation by inhibiting synthesis
and secretion of matrix proteins, and alkaline phosphatase (Kream et
al., 1980; Majeska and Rodan, 1982).

Chronic high doses of PTH have
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been shown to have an inhibitory effect on bone formation, which may
explain what was seen in this investigation (McGuire and Marks, 1974;
Tam et al., 1982) .
Mineralized matrix is essential for osteoclast function.
Osteoclasts preferentially chose mineralized matrix as a substrate
although it has been shown they are capable of resorbing a nonmineralized surface (Reid 1986).

Krukowski and Kahn (1982) grafted parti-

cles of devitalized, mineralized bone; devitalized, demineralized bone;
hydroxyappatite and egg shell onto chorioallantoic membranes, and
showed the only substrate to elicit osteoclast-like giant cells was the
mineralized bone.

They concluded factors responsible for osteoclast

differentiation lie within the matrix, specifically associated with the
mineral phase; in response to mineralized matrix, osteoclast can
differentiate at an ectopic site.

This study does not substantiate the

conclusion from Krukowski and Kahn (1982).

The role of the live,

mineralized matrix in osteoclast development is emphasized in the fetal
metatarsal coculture system.

Osteoclasts developed when marrow mononu-

clear cells were cocultured with these bone rudiments but not with
devitalized fetal metatarsals or devitalized, mineralized bone particles (Burger et al., 1982; Burger et al., 1984).

Mineralized matrix is

not the only signal for osteoclast formation.
In the composite implant, the dominant reaction to the bone
particles was an inflammatory response, similar to that seen in the
purely mineralized implant.

This response is probably due to the

presence of the mineralized matrix since an inflammatory response is
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seldom seen when demineralized bone is implanted.

The ability of this

type of implant to elicit osteoclastic cells seems to be more dependent
on the presence of the demineralized bone matrix than the mineralized
matrix.

As in the case with bone morphogenic protein, the deminerali-

zation process unlocks its inductive capabilities.

Other cytokines

which stimulate osteoclastogenesis may also be associated with the
mineralization phase of the matrix and are therefore incapable of being
released.

These cytokines which can be released from the demineralized

matrix may influence osteoclast development directly or indirectly.

In

the purely demineralized bone implants osteoclasts were not present
until mineralized matrix was formed indicating that mineralized matrix
may be needed for recruitment, maturation and/or activation.

In the

composite implant the mineralized matrix is already present and inhibits the osteoinductive potential of the demineralized matrix simply by
its presence or by the inflammatory reaction it elicits.

However, just

because osteogenesis did not occurred, does not mean that the demineralized matrix had no effect on the cells at the implant site.

The only

parameter of osteogenesis that was evaluated in this investigation was
alkaline phosphatase.

The demineralized matrix in the presence of the

mineralized matrix may not induce osteogenesis but it may continue to
cause some cellular differentiation or expression of factors to elicit
osteoclasts.

This type of implant may serve as a model of pathological

bone loss because it is able to elicit osteoclasts and inflammatory
phagocytes capable of osteolysis.

Both may play equally important

roles directly or indirectly, in bone destruction.
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l,25(0H) D was the only hormone which affected the TRAP
2 3
activity of the MNGCs in the composite implant.

The number of intense-

ly staining cells increased with l,25(0H) D treatment.
2 3

From this

investigation, I am unable to determine if (1) l,25(0H) D stimulated
2 3
an increase in TRAP expression in cells which had previously expressed
low levels of the enzyme or, (2) more cells that express high levels of
TRAP were recruited to the site.

Recruitment rather than of induced

expression seems more likely the case because more TRAP positive
mononuclear cells were seen with l,25(0H) D infusion.
2 3

If l,25(0H) D
2 3

acted as a fusogen, more TRAP positive multinucleated cells may have
been formed.

Few if any osteoclasts analyzed expressed low levels of

TRAP indicating, a high level of TRAP activity is normally seen in
osteoclasts.
The purpose of this investigation was to determine if local
hormone infusion could influence the recruitment of osteoclasts to
ectopic bone implants.

Osteoclasts could not be recruited to the site

of the mineralized bone particle implants with or without stimulation
from l,25(0H)

o

2 3

or PTH.

Osteoclasts were recruited for remodelling of

the new bone in the demineralized implants except in the PTH treated
implant, where osteogenesis and subsequent remodelling were absent.
l,25(0H) D had a stimulatory effect on the number of MNGCs expressing
2 3
TRAP activity in the composite implants.

Osteogenesis was absent

except in one l,25(0H) D treated sample and one CT treated sample.
2 3
had no effect on the MNGCs elicited by any of the implants in this
model system.

CT
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Although a number of other parameters could have been included
to evaluate the hormonal effects on formation of MNGCs, the cellular
populations elicited by the different bone implants, osteogenesis and
remodelling, this study was limited to the morphology and histochemistry of the MNGCs.

The results indicate a stimulatory role for 1,25

(OH) n in the development of osteoclasts in the composite implant.
2 3
This study also indicates that demineralized matrix may function as a
storehouse of inducing factors which may affect osteoclast development
either directly or indirectly.

The matrix is important in the

development and function of bone cells.
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Figure 1.
TRAP expression in MNGCs from mineralized, demineralized and
composite bone implants (2 wks. post-implantation) and in situ
osteoclasts from l,25(0H) n treated (T) and control (C) rats.
2 3
TRAP expression scored as high level (++), moderate level (++) and
absence (0) of reaction product. (mean ±SEM).
a. mineralized (T) (++) significantly different than tibia
(C) (++), p<0.05.
b. mineralized (T) (++) significantly different than
demineralized (T) (++), p<0.05.
c. mineralized (T) (++) significantly different than
composite (T) (++), p<0.05.
d. compostie (T) (++) significantly different than
composite (C) (++), p<0.05.
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Figure 2.
TRAP expression in MNGCs from mineralized, demineralized and
composite bone implants (2 wks. post-implantation) and
osteoclasts from PTH treated (T) and control (C) rats.

situ
TRAP

expression scored as high level(++), moderate level (+), and
absence (0) of reaction product. (mean ±SEM).
a. mineralized (T) (++) significantly different than tibia
- (C) (++), p<0.05.
b. demineralized (T) (++) significantly different than
demineralized (C) (++), p<0.05.
c. demineralized (T) (++) significantly different than
tibia (C) (++), p<0.05.
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Figure 3.
TRAP expression in MNGCs from mineralized, demineralized and
composite bone implants (2 wks. post-implantation) and in situ
osteoclasts from CT treated (T) and control (C) rats.

TRAP

expression scored as high level(++), moderate level (+), and
absence (0) of reaction

product.

(mean ±SEM).

a. mineralized (T) (++) significantly different than tibia

(C) (++), p<0.05.
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At 14 days, MNGCs elicited by a mineralized bone implant from a
1,25 Dihydroxyvitamin

n3

treated rat:

Figure 4.
Low levels of TRAP are demonstrated in MNGCs (arrows) adjacent to
mineralized bone particles (b).

x413

Figure 5.
MNGC in contact with a mineralized bone particle.

Note the

absence of membrane specialization at the cell-bone interface.
xl2000
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At 14 days, osteoclasts at demineralized bone implant from a
calcitonin treated rat:

Figure 6.
Osteoclasts (arrows) are present along the newly mineralized
matrix (b) and remodelling is in progress at the osteogenic site.
x438

Figure 7.
Osteogenic site stained for TRAP reaction product.

Osteoclasts

(arrows) along the bone (b) containing high concentrations of TRAP
reaction product.

x413
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At 14 days, MNGCs elicited by composite bone implant from a
parathyroid hormone-treated rat:

Figure 8.
MNGCs (arrows) at or near the bone (b) surface demonstrating a
range of TRAP reaction product intensities.

In the highly TRAP

postive cells note the distribution of TRAP reaction product and
the intensity of the enzyme along the bone-cell interface.

x660

Figure 9.
MNGC in contact with the bone (b), demonstrates a clear zone (c)
and ruffled border (rb), membrane specializations of osteoclasts.
x7500
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CHAPTER VII

DISCUSSION

The skeleton defines the shape of an organism.

It facilitates

locomotion, protects vital organs and functions as a storehouse for
calcium and phosphate.

It is under constant reconstruction.

Although

the gross shape remains relatively constant throughout adult life, the
matrix microstructure is being destroyed and replaced by a complex sequence of cell-mediated events.

The osteoclast is mainly responsible

for the destructive phase of the remodelling process.

Because of its

life-threating potential, the osteoclast is highly regulated, mainly
through the osteoblast, the effector cell of bone formation .

The roles

of the osteoblast in both bone formation and resorption provides a link
between the two interdependent processes.

Whether the osteoblast is

necessary for osteoclast differentiation and function is one question
addressed by the studies of this dissertation.
In this dissertation, the bone implant system, using three
different matrix preparations, has provided three models to study the
events in normal and pathological bone cell function.

The focus of the

studies have been on the bone resorption process and whether any or all
of the bone implants would provide a good model to study osteocl a st
differentiation and function.
TRAP and classic morphological features were used to identify
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osteoclasts in these implant studies.

TRAP has been accepted as a

marker of osteoclast function and has been extensively used to identify
the differentation of osteoclasts in vivo and in vitro.
demonstrated and seemed to be a reliable marker.

It is easily

However, the

specificity of this form of acid phosphatase to the osteoclast has been
questioned after its demonstration in other cells.

Its specificity be-

came particularly important since TRAP was being used to assess the
differentiation of osteoclasts in bone marrow cultures where nonosteoclastic multinucleated cells which are capable of TRAP expression were
also present.

An objective method of quantitation had never been

established to determine if a particular level of TRAP reaction product
was specifically associated with the osteoclast.

A specific level of

enzyme expression could be used to identify osteoclasts instead of the
presence or absence of the enzyme.

From the developement of one such

method of assessment, described in detail in Chapter III, a high level
of TRAP reaction product was determined to be a characteristic of
osteoclast.

The osteoclasts consistently expressed high levels of TRAP

reaction product.

With the ability to standardize the method of analy-

sis and determine a level which could characterize the osteoclast, TRAP
could again be considered an effective criteria for osteoclast identification in normal and experimental situations.
Three different bone matrix preparations were used to elicit
three different responses.

Implantation of mineral bone particles had

been shown to elicit an osteolytic response.

It seemed possible that

osteoclasts may be recruited to the site to remove bone matrix since
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mineralized bone stimulates the formation and is the specific substrate
of osteoclasts, but it seemed equally possible that the bone implant
would elicit an inflamatory response like other particulate foreign
matter and be removed by phagocytic cells.

Evidence has previously

been reported to support both the presence of osteoclasts in one case
and phagocytic cells in another.

Results from this study indicate the

lack of osteoclasts at the site of mineralized bone implants.

The

multinucleated giant cells present 14 days post-implantation which
resemble osteoclasts in some ways, fail to exhibit ruffled borders or a
high level of TRAP reaction product.
One explanation for these findings is that the devitalized
mineralized bone particles do not provide the appropriate cues necessary for the recruitment and differentiation of osteoclasts at this
ectopic site.

Mineralized bone has been shown to be a stimulator of

osteoclast formation and function however in this model, the presence
of mineralized bone alone is insufficient to promote osteoclast formation.

Burger et al. (1984) have suggested live bone, particularly the

osteoblasts population, is necessary for the differentiation of osteoclasts.

Others have also shown that osteoblasts are required for

osteoclast formation and activation in vitro (McSheehy and Chambers,
1986; Rodan and Martin, 1981).

It is evident osteoclasts are dependent

on the physical and cellular microenvirorunent in which they function.
Absence of factors at this subcutaneous site, which are normally present in the microenvirorunent of bone, may have limited the recruitment
of mononuclear precursors, their fusion, expression and/or function as
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mature osteoclasts.
Another explanation for the findings is that the inflammatory
response is the dominant response inhibiting the ability of the matrix
to stimulate osteoclastic recruitment.

The bone particles are almost

completely surrounded by multinucleated giant cells at 14 days, which
would prevent exposure of the matrix to osteoclasts.

If osteoclasts

were present, they would be in competition for contact with the bone
matrix particles.
In the final attempt to stimulate the recruitment of osteoclast
precursors and/or differentiation of osteoclasts at this ectopic site,
stimulatory hormones and interleukin 2 (IL-2) was infused.
constant infusion of 1,25 dihydroxyvitamin n

3

Direct,

(l,25(0H) D ), parathy2 3

roid hormone (PTH) and IL-2 for 14 days failed to produce osteoclasts
at the mineralized bone implant.

If osteoclasts had been present at

the site but were unable to express ruffled borders or a high level of
TRAP, the hormones may have been able to stimulate their expression.
If osteoclasts were not present at the implant site, the hormones would
be ineffective.

With these results from the hormone studies, it is

unlikely that the devitalized, mineralized implant with or without
stimulation, is able to recruit precursors or stimulate formation of
osteoclasts.

Use of this system for the study of osteoclast recruit-

ment and function would be inappropriate.

This system however, could

be used to evaulate the potential role of macrophages and macrophagederived cells in the inflammatory osteolytic process.

Mononuclear

phagocytes have been identified at sites of inflammarntory osteolysis
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and have been shown to be active participants.

Their direct contribu-

tion to the osteolytic process and their role in health and disease may
be significant.

The mineralized matrix implant may be the appropriate

model to analyze the potential of the nonosteoclastic populations in
matrix degradation and develop means to control this inflammatory bone
loss.
Implantation of a demineralized matrix elicits an osteogenic
response and has been extensively used to study the process of bone
formation. The amazing ability to stimulate the differentiation of
cells responsible for the synthesis of a mineralized bone matrix at an
extraskeletal site reveals the undifferentiated state of mesenchymal
cells, even in the adult organism, and the impact of the matrix on
these cells.

The sequence of events is highly predictable and is simi-

lar to endochondral bone formation.

By day 14 post-implantation,

osteoclasts are recruited to remodel the mineralized matrix which would
indicate this system a model appropriate for the study of both bone
formation and resorption.

The appearance of osteoclasts at the site of

the deminerailzed implants, expression of high levels of TRAP and ruffled borders were expected.

The data from the demineralized implants

were in aggreement with earlier studies however, the morphology and
histochemistry of the osteoclast had never been the focus of attention.
The differences between the osteoclasts recruited to this ectopic site
with the multinucleated cells recruited to the mineralized site further
reinforced the conclusions that the mineralized implant could not be
used as a model for osteoclastic bone resorption.
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PTH was the only hormone that affected the ability of the demineralized implant to recruit osteoclasts by inhibiting its osteoinductive capacity.

Since the osteoclasts had been expressing high levels

of the enzyme without hormone treatment, it was difficult to conclude
if the hormones enhanced TRAP expression.

The ability of the deminer-

alized implant to recruit osteoclast precursors and stimulate their
differentiation, and the potential ability to modulate these responses
again indicates the ectopic bone implant system may be a useful model
to study osteoclastic formation and function.
The results from the composite implant system proved to be the
most interesting of the three implants.
demineralized bone
sponse.

The mixture of mineralized and

matrices produce a nonosteogenic, inflammatory re-

The recruited cell population was similar to that from the

mineralized implant except for a minor population expressing high
levels of TRAP and membrane specializations reminiscent of ruffled
borders.

The dominant response as seen in the mineralizd implant is

the inflammatory reaction.

In this case, the presence of the mineral-

ized matrix and/or the inflammatory cells elicited by it, may inhibit
osteogenesis.

Even though there are no signs of bone formation, as

monitered by the expression of alkaline phosphatase, it cannot be
concluded that the demineralized bone particles had no effect.

The

results from the other 2 types of matrix implants indicates the
demineralized implant may have more of an effect on bone cell dif ferentiation than the mineralized matrix.

Urist and Strates (1970) stated

the demineralization process allows the release of factors that stimu-
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late bone formation.

It is now known that the bone matrix is a store-

house for factors that affect both bone formation and bone resorption
and stimulators of the bone resorption process may also be freed by the
extraction of the mineral phase.

The signal for osteoclast recruitment

and/or differentiation may be weak which would explain the small number
of osteoclasts that were identified.
Treatment with l,25(0H) n and IL-2 was shown to increase the
2 3
expression of the enzyme while all treatments continued to produce
cells with osteoclastic characteristics.

Unlike PTH and calcitonin

(CT) which are effectors of osteoclastic function, l,25(0H) D is
2 3
thought to be an effector of osteoclast differentiation, which may
indicate in this investigation, that l,25(0H) D is stimulating the
2 3
formation of osteoclasts at this ectopic site.

IL-2 may also have a

direct or indirect effect on osteoclast formation.
In order to effectively study the formation and function of
osteoclasts, investigators are in search of the perfect model system.
One in which an isolated pure population of osteoclasts can be used for
study.

Attempts have been made to preferentially induce the formation

of osteoclast in vitro and to isolate mature osteoclasts from the surface of the bone.

These systems have provided important information,

however they are far from ideal. The bone implant system may provide an
in vivo approach to the study of bone cell function.

From its uncer-

tain hemopoitetic origins, to the complexitiy of its function and
interactions with other cells, the osteoclast is a challenging subject
of intriguing investigation.
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In summary, the work of this dissertation has:
1.

developed an objective method to quantitate intracellular TRAP
activity and determined that there is a level of expression
specific to the osteoclast

2.

provided evidence to reject the use of the mineralized matrix
implant as a model for bone resorption due to the inability to
generate osteoclasts at the site with or without stimulation

3.

provided evidence to substantiate the presence of osteoclasts at
the site of the demineralized bone implant and propose the use
of the system to study the osteoclast

4.

introduce the composite implant as a model for inflammatory bone
loss due to the presence of osteoclasts and inflammatory giant
cells.
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APPENDIX A

A MORPHOLOGICAL, HISTOCHEMICAL AND FUNCTIONAL COMPARISON OF
THE CELLS ELICITED BY MINERALIZED BONE IMPLANTS
24 HOURS AND 14 DAYS POST-IMPLANTATION
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Cells recruited to the site of ectopically implanted mineralized
bone particles can be characterized functionally as osteolytic cells
but morphologically they do not demonstrate the hallmarks of active
osteoclasts.

Pellets of mineralized bone powder (particle size 75- 250

urn), were implanted subcutaneously on the dorsal body wall of young
adult rats.

Two weeks post-implantation, the connective tissue

encapsulated pellets were removed and processed for morphological,
histochemical and functional analyses.

Implanted pellets removed 24

hours post-implantation served as controls.

At one day after implanta-

tion, the bone particles were surrounded by mononuclear inflammatory
cells, which exhibited no TRAP activity (Fig la).

Ultrastructurally,

the mononuclear cells also failed to exhibit ruffled borders, the
hallmark morphological feature of the osteoclast (Fig lb).

In the 2

week implant samples, the bone particles were surrounded by large
multinucleated cells.

Unlike normal osteoclasts which express intense

TRAP activity, the multinucleated cells of the 2 week implants
expressed weak or total absence of TRAP activity (Fig 2a).

Ultrastruc-

turally, these cells were seen contacting the bone particles however,
ruffled borders or other membrane specializations were absent (Fig.
2b).

To evaluate the functional capabilities of these multinucleated

cells, the per cent surface area occupied by bone and the number of
particles per field were determined.

Three micron sections were

stained with von Kossa for mineral content.

The total surface area

occupied by the bone particles, 24 hrs. post-implantation versus 2 wk.
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post-implantation, was calculated using the Bioquant software package,
run on an Apple 2 computer.
also calculated.

The number of bone particles per field was

The implants exhibited a 20% reduction in bone sur-

face area (p<0.05), and a 38% reduction in particles per field compared
to controls (p<0.05).

In conclusion, although these cells appear to be

osteolytic, they do not appear to be osteoclasts.

These results indi-

cate the implantation of mineralized bone promotes a response similar
to that elicited by other particulate foreign substances.

It does not

differentially recruit osteoclasts and exposure of mineralized matrix
may be one of many signals needed to stimulate osteoclast recruitment,
differentiation, and/or function.
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Figure 1.
24 hrs. post-implantation of mineralized bone particles:
a.

Lack of MNGCs at the site of the implant at this early time
point. Lack on TRAP reactivity in mononuclear cells present.
x425

b.

Mononuclear cell in contact with a bone particle (b). xl2000
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Figure 2.
2 wks. post-implantation of mineralized bone particles:
a.

Lack of TRAP reactivity in MNGCs (arrows) in contact with
mineralized bone particles (b).

b.

x425

MNGC in contact with a bone surface (b).
membrane specializations.

xlOOOO

Note the absence of
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APPENDIX B

ELEMENTAL ANALYSIS OF A COMPOSITE IMPLANT AS·DETERMINED
BY ENERGY DISPERSIVE SPECTROSCOPY
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Elemental analysis for calcium, phosphorus and zinc superimposed
on a scanning electron micrograph of a composite implant prior to
implantation as determined by energy dispersive spectroscopy (EDS).
Particles (75-250 um diameter) were prepared per Material and Methods,
Chapter IV, coated with gold and analyzed using the Princeton Gamma
Tech System 4+ and JEOL JSM-840A scanning electron microscope.

The

horizontal line (at arrow) represents the scan line for the collection
of X-ray counts.

The superimposed spatial distribution of counts

within the energy window for phosphorus (a) and calcium (b) indicates
high levels of these elements in the bone particle (Bl) low levels in
bone particle (B2).

The spatial distribution of counts within the

energy window for zinc was used to assure the changes in above counts
were unrelated to the geometric profile of the particles at the level
of the scan line.
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